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ABSTRACT 
Parietal cells play a fundamental role in stomach physiology, not only by 
creating a pathogen free environment through the production of gastric acid, but 
also by secreting essential growth factors thought to be important for cellular 
homeostasis of the gastric glands. The gastrointestinal hormone gastrin is known to 
be a critical regulator of parietal cell function as well as proliferation and 
differentiation of the gastric glands. High gastrin levels in the body are frequently 
associated with gastric hyperplasia, yet the mechanism has not been defined. Since 
parietal cells contain gastrin receptors, one hypothesis is that the proliferation effect 
of hypergastrinemia is due to gastrin stimulation of growth factor(s) from parietal 
cells. Recent gene expression microarray studies of mouse stomach mucosa 
identified parathyroid hormone-like hormone (Pthlh) as a potential new gastric 
growth factor. Pthlh is expressed widely and has been described to orchestrate key 
cellular events in different tissues, such as cell proliferation and differentiation. 
Although Pthlh is highly expressed in gastric tumors, its normal expression, function 
and regulation in the stomach have not been studied. In this dissertation I examined 
the physiological importance of Pthlh in the mouse stomach.  I used pharmacologic 
and genetic mouse models as well as human gastric cancer cell lines to determine 
the cellular localization and regulation of this growth factor by the hormone gastrin. 
Analysis of PthlhLacZ/+ reporter mice localized Pthlh to parietal cells in the gastric 
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corpus. Acute treatment of mice with gastrin rapidly and transiently increased Pthlh 
mRNA abundance. Accordingly, Pthlh expression was significantly reduced in 
gastrin-deficient mice. Together these data suggested that gastrin is a physiologic 
regulator of Pthlh in the gastric mucosa. To examine the mechanism, human gastric 
AGS-E cells treated with gastrin exhibited a robust induction of endogenous Pthlh 
mRNA via stimulation of the gastrin receptor (Cckbr). Pharmacologic inhibitor 
studies demonstrated that PI3K, PKCα, Erk1/2 and p38 MAPKs signaling were 
required for this induction. Furthermore, gastrin induced Pthlh mRNA isoforms that 
arose from different promoters. The rapid response and co-regulation of numerous 
molecular forms suggested that gastrin signaling targets the Pthlh mRNA stability 
elements in the 3’- untranslated region. Measurement of mRNA half-life confirmed 
that gastrin slowed the degradation of Pthlh transcripts. 
 The Hedgehog (Hh) signaling pathway is a key signaling pathway in 
gastrointestinal development, differentiation and homeostasis. Some studies 
suggested the regulation of Hh signaling components by gastrin. Since Pthlh gene 
expression regulation by the Hh signaling pathway is prominent in bone 
morphogenesis and mammary differentiation, we wanted to test the possible 
mediation of Hh pathway in the induction of Pthh gene expression by gastrin. There 
were no changes in the gastric expression of the Hh pathway components in both, 
gastrin mutant and acutely gastrin-treated mice. Several Hh mutants, including 
H+,K+-Cre/Shh-/-, Gli2 and Gli3, demonstrated no change in Pthlh expression, 
suggesting that the Hh pathway does not regulate Pthlh gene expression in the 
stomach.    
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  Last, to understand Pthlh function I analyzed Pthlh mutant mouse stomachs 
at E18.5 and found no major differences between mutant and control embryos. This 
suggested that Pthlh is not required for early stomach development. However, the 
report of high maternal Pthlh in amniotic fluid challenges this conclusion and the 
function of Pthlh in the stomach remained to be determined. 
Collectively, this dissertation identified Pthlh as a novel parietal cell growth 
factor. It also identified Pthlh as a potential mediator of gastrin growth factor 
activity in the stomach. 
1 
CHAPTER 1 
INTRODUCTION 
1.1 THE STOMACH 
1.1.1 ANATOMY AND COMPARTMENTS 
The stomach is a muscular and secretory organ of the upper digestive 
system. Upon macroscopic examination, three compartments of the adult mouse 
stomach can be distinguished by color and thickness. They include: forestomach, 
corpus and antrum (Figure1-1, A and B). The forestomach is the most proximal 
compartment and is composed of squamous epithelium. The corpus and antrum, 
however, represent the glandular part of the stomach. The corpus, which is the 
middle compartment, is responsible for secreting gastric acid and digestive proteins, 
including pepsinogen. The corpus is also the thickest among the three 
compartments (Figure 1-1, C). The most distal region is the antrum, which has 
modest mucosal depth (Figure 1-1, E). The antrum is rich with endocrine cells 
responsible for secretion of the hormone gastrin. In the mouse stomach, the 
esophagus connects to the forestomach from the lesser curvature side, while the 
small intestine connects to the antrum.
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Figure 1 -  1 Mouse stomach anatomy 
A, The stomach is divided to three regions: forestomach, corpus and antrum. B, 
adult mouse stomach opened along the greater curvature with transitions 
between forestomach and corpus (blue dashed line), and between corpus and 
antrum (red dashed line) highlighted. C-F, Hematoxylin and eosin stained 
sections and diagram of a gastric gland from corpus C-D, and antrum E-F. 
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1.1.2 GASTRIC GLAND STRUCTURE 
The gastric glands form the functional units of the stomach. They are formed 
from evaginations of mesenchymal tissue covered with columnar epithelial cells. 
The mesenchymal layer is composed of connective and smooth muscle tissues, 
enteric nervous cells, immune cells, as well as blood vessels. The epithelial cellular 
composition and the architecture of the gastric gland are different in corpus and 
antrum (Figure 1-1 C-F). 
 In corpus, the gastric gland is divided into four regions: the pit, the isthmus, 
the neck and the base (Figure 1-1, D). The corpus epithelium is composed of several 
differentiated cell types, which each localizes differently along the gastric gland and 
has specific secretory functions: (i) Surface mucous cells, which are located in the pit 
region of the gastric gland and secrete mucous to protect the stomach epithelium 
from pathogens, strong acid and digestive enzymes present in the lumen; (ii) 
Mucuos neck cells, located in the neck region, also secrete mucous and are 
zymogenic precursor cells;  (iii) Zymogenic cells, located at the base, secrete 
pepsinogen, an acid-activated protease that contributes to digestion; (iv) Parietal 
cells, which migrate bi-directionally along the pit-base axis of the gastric gland, 
secrete hydrochloric acid (HCl) to help in food digestion and to make the gastric 
environment unfavorable for pathogens. The parietal cells have also been shown to 
be critical for proper cellular differentiation of the gastric epithelium, as will be 
discussed later; (v) Enterochromaffin-like cells (ECL), which secrete histamine, and 
as a result, stimulates parietal cell acid secretion. These endocrine cells are located 
Lesser 
curvatur
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towards the base of the corpus gastric gland. All of these cells are differentiated 
from a stem/progenitor cell population located in the isthmus.  
In antrum, the gastric gland epithelium (Figure 1-1, F) is composed of: (i) 
Surface mucous cells; (ii) Deep mucous cells; and (iii) G cells, which are the gastrin- 
producing endocrine cells. Gastrin hormone, as will be discussed later, is 
responsible for stimulating acid secretion from the corpus and has a potent growth 
effect in the corpus. The antral stem cell population is located in the base of the 
gland. 
In addition to ECL and gastrin cells there are several endocrine cells that are 
located in both corpus and antrum and thought to be important for stomach 
physiology. These  include: Enterochromaffin (EC) cells which secrete serotonin, D 
cells which secrete somatostatin and X (or A-like) cells which secrete ghrelin1.  
1.1.3 EPITHELIAL CELL HOMEOSTASIS: PROLIFERATION AND 
DIFFERENTIATION 
The gastric epithelium is continuously replaced from stem cells located in the 
isthmus of the gastric gland2. This dynamic process of continuous cell production 
and turnover of the gastric epithelium is fundamental for the organization of the 
epithelium and its capacity for protection, secretion and adaptation3. The stomach 
expresses  several growth factors, including Heparin-Binding Epidermal-Like 
Growth Factor (HB-EGF)4, Sonic Hedgehog (Shh)5, Insulin Growth Factor Binding 
Protein 2 ( Igfbp2)6, which are thought to be important for gastric epithelial cell 
differentiation and maturation.  
5 
 In corpus, stem cells located in the isthmus of the gland (Figure 1-1, D) give 
rise to all of the differentiated cell types of the gastric mucosa. Elegant studies by 
Karam and Leblond have described the cell lineages in the adult mouse stomach2, 3, 7-
9. Lineage precursors differentiate to committed cells that express lineage specific 
markers during their differentiation program3, 7-9 (Table 1-1). (i) Surface mucous 
cells are the most rapidly turned over cell type, with a lifespan of 3 days7, are 
marked by Muc5AC. (ii) Mucous neck cells spend 7 to 14 days in the gland neck 
region as they move towards the base and further differentiate into zymogenic 
cells8. Muc6 and TFF2 are specific markers for mucus neck cells. (iii) Zymogenic 
cells have a long lifespan of ~194 days8 and express intrinsic factor in the mouse 
stomach. (iv) Parietal cells are estimated to turnover in 54 days9,  with the proton 
pump H+,K+-ATPase as a specific marker. (v) ECL cells secrete histamine, which 
stimulates parietal cell acid secretion. HDC is an ECL cell-specific marker. 
 Although the function and the characterization of the gastric corpus gland 
has been well studied, the pathways controlling cell proliferation versus 
differentiation or controlling cell numbers are not understood. As will be discussed 
below, several studies concluded that the hormone gastrin has a growth effect in the 
stomach; however the mechanism is yet to be defined. Moreover, changes in 
epithelial cell differentiation in different mouse models with loss or ablation of 
parietal cells, suggested that instructive messages are sent from parietal cells to 
other lineages in the stomach to regulate gastric epithelial cell homeostasis. These 
mouse models will be reviewed in the next section.
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Table 1 – 1:  Cell markers of differentiated mouse corpus epithelial cells 
Cell Type Marker 
Surface 
mucous 
Mucin 5, subtypes A and C (Muc5AC) 
Mucous neck Mucin 6 (Muc6) and Trefoil Factor 2 (TFF2) 
Parietal H+,K+-ATPase, α (ATP4A) and β (ATP4B) subunits 
Zymogenic Intrinsic Factor (IF) 
ECL Histidine decarboxylase (HDC) 
Tuft  
Doublecortin-Like Kinase 1 (DCLK1) and Acetylated-α-Tubulin 
(acTub) 
D Somatostatin (SST) 
X (or A-like)  Ghrelin (GHRL) 
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1.2 THE PARIETAL CELL 
1.2.1 IMPORTANCE OF PARIETAL CELLS FOR GASTRIC HOMEOSTASIS 
The parietal cell is a key component of a healthy stomach. The disruption or 
ablation of parietal cells is always associated with imbalanced gastric homeostasis. 
The basic function of the parietal cell is acid secretion, and this function is important 
for many reasons. First, gastric acid provides an environment that limits pathogen 
survival in the stomach. Studies in the gastrin-deficient mouse, which have low 
gastric acid, showed that low acid can cause bacterial overgrowth chronic gastritis 
and emergence of distal tumors that progressed to adenocarcinoma10. Second, the 
activation of digestive enzymes in the stomach occurs in parallel with gastric acidity. 
For example, the conversion of the zymogenic cell enzyme pepsinogen to its active 
form pepsin is dependent on low gastric luminal pH11. Third, the processing and 
regulation of some gastric growth factors have been shown to be regulated by 
acid12. Zavros et al demonstrated the requirement of acid produced by parietal cells 
for the processing of Shh from 45-kDa to its active19-kD form12. Last, gastric acid is 
also found to be critical for body bone density and calcium homeostasis13, 14. Recent 
studies have made a connection between impaired gastric acidification, calcium 
absorption and osteoporosis in gastrin receptor-deficient mice13, 14.    
In the literature, the parietal cell has been described as “mitochondrion-
laden, proton-secreting factories” 15. Genes involved in energy production and acid 
secretion are highly expressed in parietal cells6, 15, 16. In addition, recent studies 
8 
found the expression of novel factors thought to be important for gastric mucosal 
homeostasis6, 16, as it will be discussed in the next section. 
1.2.2 PARIETAL CELL AND GROWTH FACTORS 
In addition to acid secretion, parietal cells express and respond to several 
growth factors. The gastrin/cholecystokinin B receptor (Cckbr) and the epidermal 
growth factor (EGF) receptor have been found to be expressed in parietal cells17, 18. 
Studies also showed the ability of parietal cells to express a number of growth 
factors. A microarray analysis for parietal cell-enriched preparations showed that 
parathyroid hormone-like hormone (Pthlh), vascular endothelial growth factor B ( 
Vegfb), and insulin-like growth factor-binding protein 2 (Igfbp2) are expressed in 
parietal cells16.  Other microarray studies from wild type and gastrin-deficient mice 
confirmed the previous results, but also suggested for the first time the regulation of 
Pthlh, Igfbp2 and Vegfb by gastrin6, 19. These studies also suggested that targets of 
Wnt and Myc signaling, which are usually stimulated in proliferating cells, are 
regulated by gastrin in the parietal cell6. The Hedgehog ligands Shh and Indian 
hedgehog (Ihh) were also expressed by parietal cells5, 6, 20.The expression of growth 
factors suggests a potential mechanism for parietal cell regulation of stomach 
growth.  
The possibility that parietal cell growth factors are responsible for the 
proliferation/differentiation imbalance seen in mouse models with impaired 
parietal cell function is an intriguing hypothesis. Table 1-2 summarizes several 
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Table 1 – 2: Mouse models with reduced function/ablation of parietal cells 
Mouse Model Reference 
Diphtheria toxin-transgenic mouse 16, 21 
DMP777-treated mouse 22, 23 
H+,K+-ATPase-deficient mice 24, 25 
Gastrin-deficient mouse 26, 27 
Huntington interacting protein 1 related-deficient mouse 28, 29 
Cholecystokinin B receptor-deficient mouse 30 
Histamine receptor-deficient mouse 31 
Parietal cell-specific Sonic hedgehog-deficient mouse 32 
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parietal cell loss/ablation models.  In general, these models share the following 
phenotypes: (i) the differentiation program of zymogenic cells is blocked with 
accumulation of aberrant mucus neck cells referred to as spasmolytic polypeptide-
expressing metaplasia (SPEM)33; (ii) the expansion of surface mucous cells; (iii) 
increased proliferation, and (iv) high serum gastrin levels. In an elegant study, 
Keeley et al compared the postnatal development of the gastric glands in 
Huntington interacting protein 1 related (Hip1r)-deficient mice to wild type mice28. 
The study found that the changes in zymogenic lineage differentiation and the 
expansion of mucous cells do not appear until after parietal cell loss in the Hip1r-
deficient mouse. This study concluded that parietal cell loss was the initiating event 
in Hip1r-deficient mice, with secondary remodeling of the other cell types28, 
suggesting that parietal cells are critical for maintenance of gastric epithelial cell 
homeostasis. 
1.3 GASTRIN HORMONE 
Gastrin, a key gastric hormone required for gastric homeostasis, is expressed 
by the antral G cells (Figure 1-1, F) and is processed from its precursor form to give 
the mature amidated-end products: gastrin-17 and gastrin-3434.  Gastrin is released 
into the bloodstream via an endocrine mechanism, where it travels back to its target 
cells in the gastric corpus (parietal cells and ECL cells). Gastrin-Cckbr receptor 
interaction induces gastric acid secretion27, 35 as well as gastric epithelial cell 
proliferation29, 36, 37. This section will present an overview of: (i) gastrin’s role in acid 
secretion; (ii) gastrin and its potential growth effects; (iii) Cckbr signaling 
11 
stimulation mediating the proliferative role of gastrin and; (iv) gastrin regulation of 
target gene expression. 
1.3.1 STIMULATION OF ACID SECRETION 
For many decades, gastrin has been known as the physiologic stimulator of 
gastric acid secretion. In response to meal ingestion, gastrin is released from the 
antrum and stimulates acid secretion from the parietal cells of the corpus35. Gastrin 
acts via both direct and indirect mechanisms to activate gastric acid secretion35. The 
direct pathway occurs when gastrin binds to its receptor on parietal cells, resulting 
in the stimulation of cellular phospholipase C (PLC), increased inositol 
trisphosphate (IP3) and Ca2+ release from intracellular stores in the endoplasmic 
reticulum38. This influx in Ca2+ has been demonstrated to be required for 
stimulation of acid secretion39. Parietal cells then undergo a morphological change 
in which intracellular membrane organelles, known as “tubulovesicles”, migrate and 
fuse with the parietal cell apical membrane, increasing membrane surface area, and 
therefore enabling acid release via H+,K+-ATPase proton pump35, 40. In the indirect 
pathway gastrin binds Cckbr on the ECL cell to release histamine, which is a potent 
acid secretagogue41. Parietal cells express the histamine receptor H2, and therefore 
secrete acid when stimulated by histamine35. Importantly, it is known that high 
gastric acid content inhibits gastrin release and as a result reduces stimulation of 
the corpus to secrete acid35. 
12 
1.3.2 GASTRIN AND ITS POTENTIAL GROWTH EFFECTS 
Understanding the pro-proliferative effects of gastrin on the stomach has 
been a very active area of research.  It is currently unknown how gastrin promotes 
cellular proliferation, since Cckbr has only been defined on differentiated cells and 
not progenitor cells. Many different experimental approaches have been used to 
study gastrin as a growth factor in the stomach. These studies included gastrin 
treatment42-46 , pharmacologic inhibition of acid to stimulate gastrin release36, 47, 
antrectomy surgeries to delete the gastrin-secreting region36, 45, fasting-refeeding 
models37 , and genetically engineered models27, 48.  
Treatment of mice with progastrin; an unprocessed form of gastrin peptide; 
showed induction of corpus total nucleic acids and protein, indicating that gastrin 
induces hyperplasia42, 44. Administration of omeprazole, an acid secretion inhibitor, 
in chicken, hamsters and guinea pigs caused a significant increase in serum gastrin 
levels47. Accordingly, the proventriculus/stomach size, weight and corpus mucosal 
thickness were increased47. In chronic omeprazole treated rats, increased serum 
gastrin levels caused a significant, yet modest overall increase in proliferation rate36. 
Interestingly, ECL-cell proliferation was clearly pronounced in these animals. 
Importantly, the omeprazole-induced increase in proliferation and ECL replication 
were not observed in antrectomized rats, suggesting that the trophic effect in the 
stomach is likely due to hypergastrinemia 36. Also, key work from Walsh and 
colleagues showed that the induction of gastric proliferation observed in rats after a 
cycle of fasting/re-feeding was abolished when rats were pre-treated with gastrin 
13 
neutralizing antibodies37. Together, these studies suggested a critical role for gastrin 
in gastric epithelial cell proliferation.  
More recent studies used genetically engineered mouse models in addition to 
microarray analyses to study gastrin function6, 19, 26, 27, 48. The creation of the gastrin-
overexpressing transgenic mouse (INS-gas) confirmed the sufficiency of gastrin to 
increase mucosal height and proliferation rates48. Surprisingly, the gastrin-deficient 
mouse had normal mucosal thickness and normal proliferation rates26, 27. The 
expression of parietal and ECL differentiation markers, however, was reduced in the 
gastrin-deficient stomach26. These findings suggested that gastrin is not required for 
the proliferation and differentiation of the epithelial gastric cell lineages in the 
corpus, however, it is required for maturation of parietal and ECL cells26, 27. These 
findings also suggested that other factors might mediate gastrin’s effect on cell 
growth.  
More recent studies have looked at genes regulated by gastrin using gene 
expression profiling microarray analyses of gastrin-deficient mouse stomach6, 19. 
These studies showed that: (i) growth factors and mitogens like Pthlh, Ihh, Igfb2, as 
well as  Wnt signaling targets are regulated by gastrin in parietal cells; (ii) cell 
lineage specific markers like H+,K+-ATPase for parietal cells and HDC for ECL cells 
were regulated by gastrin, which agreed with previous studies characterizing 
gastric epithelial cells in gastrin-deficient mice6, 19, 26, 27. 
Chapter 2 of my thesis will present evidence demonstrating that Pthlh is 
regulated by gastrin. 
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1.3.3 GASTRIN SIGNALING VIA CCKBR 
Gastrin hormone binds to the Cckb receptor, which is a member of the G 
protein- coupled receptor (GPCR) super family. Cckbr is expressed broadly in 
normal and diseased gastrointestinal tissues49-53. In the mature stomach, Cckbr is 
expressed in parietal cells and ECL cells35, and one study claims occasional 
expression of Cckbr in TFF2-expressing progenitor cells, although this has not been 
confirmed52. 
  Although the importance of Cckbr expression in gastric acid secretion is well-
studied, it is not completely clear how the activation of this receptor might induce 
stomach growth, especially with this pattern of expression in differentiated cell 
types (parietal and ECL), but not in stem/progenitor cells.    
When Cckbr is stimulated by gastrin, a network of signaling pathways is 
activated (Figure 1 – 2). In this section, well-characterized pathways will be 
summarized, highlighting key known players. More details about Cckbr signaling are 
reviewed in the following references54-58. One thing to note is that activation of 
Cckbr signaling pathway(s) is highly dependent on the cellular context, thus Cckbr 
signaling activated in parietal cells, as an example, may be different than activated 
Cckbr on an ECL cell or a cancer cell.  
Four main signal transduction pathways are activated to promote gastric 
epithelial cell proliferation when gastrin binds Cckbr. This includes:  
I. Ca2+ mobilization and activation of protein kinase C (PKC) 
A B C D 
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Figure 1 -  2:  Signaling pathways activated upon Cckbr stimulation by 
gastrin.   
A, When gastrin binds to the G protein–coupled receptor Cckbr, activated PLCβ 
stimulates plasma membrane protein PIP2, and as a result the second 
messengers IP3 and DAG are formed to cause Ca2+ release. In addition, Cckbr 
activation can stimulate the EGFR (B), MAPK (C) and PI3K (D) signaling pathways 
(see text).  However, the precise mechanism of activation of these pathways is 
not completely defined.  In addition to other unknown mediators, PKC has been 
shown to mediate the activation of EGFR and MAPK pathways. The small G 
protein Ras exchanges GDP with GTP when stimulated by the PKC or EGFR 
signals. This causes the activation of Raf, MEK1/2 and Erk1/2 kinases to affect 
downstream target genes. Ro-32-0432, AG 1478, PD 98059, SB 203580 and LY 
294002 (black boxes) are commercially available inhibitors for PKC, EGFR, 
Erk1/2, p38 or PI3K signaling pathways, respectively.   
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The PKC pathway is highly active when gastrin stimulates Cckbr. When gastrin 
binds Cckbr, the dissociated Gq protein from the Cckbr activates the β form of 
phospholipase C (PLC), which is required for the hydrolysis of phosphatidyl inositol 
4, 5 bisphosphate (PIP2) in the plasma membrane to produce two second 
messengers: (i) inositol 1,4,5-triphosphate (IP3) and (ii) 1,2-diacylglycerol (DAG). 
IP3 rapidly and transiently releases Ca2+ from the intracellular stores after binding 
to the ligand-gated Ca2+ channels found on the endoplasmic reticulum. The second 
messenger DAG however, directly activates the protein kinase C (PKC). 
II. Mitogen-Activated Protein Kinase Stimulation (MAPK) 
Although it was first known to be activated by mitogens, the MAPK pathway 
can also be activated by hormones, neurotransmitters and stress. Stimulation of the 
MAPK pathway can result in cell growth, differentiation, survival, apoptosis and 
activation of the immune response55. Classically, small G proteins are stimulated by 
substituting bound GDP for GTP. Then, a cascade of serine/threonine 
phosphorylation by three major kinases takes place: (MAPKKK), (MAPKK) and 
MAPK.  Only Erk1/2 and p38 will be briefly discussed, due to their activation during 
induction of many genes regulated by gastrin (Table 1-3).  
Erk1/2 is the most common MAPK signaling pathway that takes place in 
gastric epithelial cells. Typically, the membrane associated small G protein Ras is 
activated, causing the activation of the MAPKKK Raf, which phosphorylates the 
MEK1/2 MAPKK. This leads to the stimulation of the Erk1/2 MAPK, resulting in 
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Table 1 - 3: Genes and molecules regulated by signaling pathways downstream of Cckbr 
Gene PKC Erk1/2 P38 EGFR PI3K Reference 
Chromogranin A (CgA) ✓ ✓ X N.D. X 59 
Cyclooxygenase 2 (COX2) N.D. X ✓ N.D. ✓ 60 
Interleukin 8 (IL8) N.D. X ✓ N.D. ✓ 60 
Trefoil Family Factor 1 (TFF1) ✓ ✓ N.D. X N.D. 61 
Trefoil Family Factor 2 (TFF2) ✓ ✓ N.D. X ✓ 52 
Matrix Metalloproteinase 9 (MMP 9) ✓ ✓ N.D. X N.D. 62 
Histidine Decarboxylase (HDC) ✓ N.D. N.D. N.D. N.D. 63 
Myeloid Cell Leukemia Sequence (Mcl 1) ✓ ✓ N.D. N.D. X 64 
Nuclear Factor K B (NFKB) ✓ X X X N.D. 65 
Heparin-Binding Epidermal-Like growth Factor (HB-EGF) ✓ ✓ N.D. ✓ ✓  66 
✓ = Regulated 
X = Not regulated 
N.D. =Not determined 
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activation of c-myc, Elk and histone H3, all of which are important for cell 
proliferation55.  
The MAPK/p38 is another key kinase mediating the regulation of different 
genes by gastrin. When human pancreatic cancer cells (AR4–2J), which express the 
Cckbr receptor, were stimulated by gastrin, the activated small G protein Cdc42 
caused a series of phosphorylation events, leading to the activation of p3857. Again, 
the direct activation between the GPCR Cckbr and the MAPK pathway is poorly 
understood. Different signaling pathways such as PKC, EGFR and PI3K can mediate 
their activation by gastrin.  
III. Epidermal growth factor receptor signaling (EGFR) 
Many hormones and growth factors signal via receptors with intrinsic 
tyrosine kinase motifs on their intracellular domains54. EGF ligand binds to the 
receptor EGFR to activate the adaptor protein src homology/collagen (Shc). 
Subsequently, Shc binds to the protein complex growth factor-receptor binding 
protein 2 (Grb2) and son of sevenless (Sos). This Grb2/Sos complex activates the 
membrane small G protein Ras, which in turn activates the Erk1/2-MAPK pathway. 
Since Cckbr does not maintain intrinsic tyrosine kinase motifs, and because gastrin 
is known to regulate HB-EGF ligand, which is expressed along with its receptor, in 
parietal cells66, the stimulation of proliferation by gastrin via this pathway is 
indirect. 
IV. Phosphoinositide 3-kinase (PI3K) 
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This pathway is required for mitogenesis as well as cellular anti-apoptotic 
and metabolic regulation55. As in the MAPK pathway, there are three key kinases: (i) 
PI3K, (ii) PKB/Akt, and (iii) GSK-3 and mTOR. Todisco et al. has shown that AR4-2J 
cells treated with gastrin activated GSK-3 protein via the Cckbr receptor56. 
Additionally, COX2, IL8 and TFF2 genes are regulated by gastrin via the PI3K 
pathway52, 60. 
1.3.4 GASTRIN REGULATION OF GENE EXPRESSION 
1.3.4.1 TRANSCRIPTIONAL REGULATION BY GASTRIN 
In 1977, Enchos and Johnson et al. showed that a single injection of 
pentagastrin in rats significantly increased total corpus mRNA within one hour, 
followed by an increase in total corpus protein that peaked at 6 hours post-
injection42. Subsequently, total corpus DNA peaked at 16 hours post-injection42. The 
sequence of these molecular events resembles the process of active cellular 
divisions taking place in a growing tissue, with the synthesis of RNA, protein and 
DNA taking place, correspondingly. Interestingly, pre-treatment of rats with 
actinomycin D, a potent mRNA synthesis inhibitor, prior to pentagastrin 
administration, eliminated protein synthesis42. This study clearly shows that 
increased protein synthesis is dependent on prior mRNA synthesis. It also questions 
the identities and effects of upregulated genes on gastric growth after gastrin 
stimulation.  
Different studies have examined gastrin regulation of gene transcription by 
using promoter serial deletions or point mutations, or electrophoretic mobility shift 
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assays (EMSA) and Western blot analyses, as well as pharmacological inhibitors52, 59-
64, 66-69. Gastrin-regulated genes are listed in (Table 1 – 4) highlighting their cis and 
trans DNA elements. A careful look at the list suggests that diverse cellular functions 
can be regulated by gastrin. For example, the listed regulated genes are: (i) 
endocrine gene targets like Chromogranin A and Glucagon59, 60, 63, 67-69 , (ii) vesicular 
transport genes like VMAT2 70, (iii) mucosal protection and repair genes like TFF1 
and TFF252, 61, (iv) inflammatory response genes like IL-8 60 ,(v) cell growth genes 
like HB-EGF66 and cyclin D171, 72, (vi) and death genes like PAI-273. Furthermore, the 
trans elements are important proteins for early development as well as cancer cell 
development. Although there are still some cis and/or trans elements yet to be 
defined, we can appreciate the clear connection between the nature of the function 
of these regulated genes and the multi- effect of gastrin on the stomach in both 
normal and disease states. 
1.3.4.2 POST-TRANSCRIPTIONAL REGULATION BY GASTRIN 
  Recently, Subramaniam et al 60 studied the ability of gastrin to regulate 
cyclooxygenase 2 (COX-2) and interleukin-8 (IL-8) genes at the post-transcriptional 
level. This study suggested that gastrin can stabilize the mRNAs of both genes and as 
a result protect the mRNAs from quick degradation, by increasing the half-life of the 
mRNAs. Morover, this study suggested the involvement of the HuR protein, which 
binds the IL-8 and COX-2 mRNAs and protects them from degradation via the p38 
MAPK pathway. This is the first study demonstrating the post-transcriptional 
regulatory role of gastrin. 
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Table 1 - 4 : Gastrin responsive elements 
   
Gene Cis-element 
Transcription 
factor 
Reference 
Chromogranin A (CgA) 
GCGGGGGGGCGG Egr1/Sp1 
59, 67 
TGACGTAA CREB 
Trefoil Factor Family 1 (TFF1) GGCGGGAGGG SP1/MAZ 61 
Trefoil Factor Family 2 (TFF2) 
CCAATA N.D. 
52
 
CCCTGTGG N.D. 
Heparin-Binding Epidermal-Like Growth Factor  
(HB-EGF) 
CGGCGCCGGGCG N.D. 66 
Histidine Decarboxylase (HDC) 
CCCTTTAAATAAAGGGCCCACACTGG N.D. 63 
TGCCAGGGAGTGCGCAGGAC N.D. 68 
Vascular Monoamine Transporter-2 (VAMT2) CCCCTCCGCCC AP2/Sp1 70 
Cyclooxygenase-2 (Cox2) N.D. AP1 60 
Interleukin-8 (IL-8) N.D. NFKB 60 
Glucagon GAGTGGGTG Egr1 69 
Plasminogen Activator Inhibitor-2 (PAI-2) TGGGAGGG MAZ/ASC1 73 
Cyclin D1 AACGTCACA CREB/β-catenin 71, 72 
N.D. = Not determined 
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Chapter 2 of my dissertation will show evidence for gastrin stimulation of 
Pthlh mRNA expression. 
1.4 THE HEDGEHOG SIGNALING PATHWAY 
A key molecular signaling pathway involved in stomach development and 
gastric epithelial cell differentiation is the Hedgehog (Hh) pathway. Previous studies 
demonstrated that changes in Hh expression are associated with either congenital 
or pathogenic gastric conditions. For example, Hh has been shown to be crucial for 
normal mammalian gastric development74-76, required for gastric tumor growth18 
and associated with human inflammatory gut diseases5, 77. All of these actions take 
place through epithelial-mesenchymal interactions20. There are three mammalian 
forms of Hh: Sonic hedgehog (Shh), Indian hedgehog (Ihh) and Desert hedgehog 
(Dhh). Shh and Ihh ligands demonstrate different yet overlapping expression 
patterns in the developing as well as the mature gastric epithelium20, 32, 74. When Hh 
ligands bind to the patched (Ptc) receptor, the inhibitory action of Ptc on the 
membrane protein smoothened (Smo) is released. As a result, the glioma-associated 
oncogene homolog (Gli) transcription factors are activated and translocated to the 
nucleus to regulate transcription, including Ptc, Gli, hedgehog interacting protein 
(HIP1) and others. Gli1, Gli2 and Gli3 have different stimulatory and/or inhibitory 
effects on target gene expression in a tissue-specific manner75, 78-81. Different studies 
have previously examined the expression of Hh signaling components in the 
stomach5, 20. In the developing and adult stomach, Shh and Ihh were found to be 
expressed in the epithelium and Ptc and Gli1 were expressed in the mesenchyme20. 
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1.4.1 GASTROINTESTINAL TRACT DIFFERENTIATION AND REGULATION BY 
HEDGEHOG 
Several genetically-engineered mouse models demonstrated the importance 
of the Hh pathway for stomach development32, 74, 75. Analysis of Shh-deficient (Shh 
KO) embryos at day E18.5 showed a reduction in stomach size, with reduced 
smooth muscle formation74. Shh KO stomachs exhibit an impressive overgrowth of 
the gastric epithelium, with alterations in cellular identity suggesting intestinal 
transformation74. This was demonstrated by histochemical staining with WFA lectin, 
normally specific for the brush border of enterocytes in the intestine74. A striking 
finding with this mutant was that gastric overgrowth is not associated with 
increased proliferation rates74. Subsequent studies done by Kim et al compared the 
stomachs of Shh, Gli2 and Gli3 knockouts to find which Gli is the critical transducer 
of the Hh signal at day E18.575. They found that although there was a mild Gli2 KO 
phenotype in the stomach, the Gli3 KO was phenotypically similar to the Shh KO. 
Gli3 mutants had glandular expansion with intestinal transformation of the 
stomach. The authors suggest that this finding supports a critical role for Hh and 
Gli3 in regulating glandular development in the stomach75. Gli3 has been 
characterized as a transcriptional inhibitor80, 81 or activator78, 79, 82 depending on the 
cellular context. The finding that Gli3 null mice mimic the Shh-deficient embryos 
phenotype suggests that it acts as an activator in the stomach. Moreover, Kim et al 
related the epithelial overgrowth in Shh and Gli3 mutants to decreased apoptotic 
cell death75. Also, histochemical analysis with different gastric cell markers 
demonstrated the presence of parietal cell, chief cell, neck and surface mucous cell 
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markers in the Hh mutants, thus challenging the original conclusion of intestinal 
transformation75. This study concluded that Shh restrains the rapid growth of 
developing gastric glands through decreasing cellular apoptosis75. Although these 
studies suggested the importance of Hh signaling for gut development and gastric 
cytodifferentiation, they did not identify a mechanistic pathway responsible for the 
gastric epithelial cell lineage expansion of parietal and zymogenic cells. These 
studies are limited because of qualitative analyses and the perinatal death of Hh 
pathway mutants.  
In the adult stomach, Hh was first studied by treating mice with the Hh 
signaling inhibitor cyclopamine83. Treated mice had decreased expression of 
putative Hh targets like the hepatocyte nuclear factor 3 β (HNF3β) and bone 
morphogenetic protein 4 (BMP4)83. Moreover cyclopamine-treatment caused 
increased proliferation, suggesting that Hh is a negative regulator of gastric gland 
epithelial cell proliferation83. Recently, mice with a specific deletion of Shh in 
parietal cells (H+,K+-Cre/Shh-/-) were described to exhibit transformation of the 
gastric mucosa32. The H+,K+-Cre/Shh-/- mouse showed multiple cellular changes: (i) 
expansion of surface mucous cells, (ii) increased proliferation rate, especially in the 
pit of the gland, (iii) nuclear localization of β - catenin, (iv) induction of cyclinD1, 
Wnt5a, Wnt3a, Gli1, Snail and Ihh, (v) impaired acid due to abnormal parietal cell 
tubulovesicles, and (vi) hypergastrinemia. These findings showed that parietal cell 
expression of Shh is critical for stomach homeostasis32. 
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1.4.2 REGULATION OF HEDGEHOG SIGNALING BY GASTRIN 
There are three studies that suggest regulation of the Hh signaling pathway 
by gastrin. First, Jain et al described upregulation of Ihh expression in gastrin-
deficient parietal cells6. Data from this study suggested the possible inhibitory role 
of gastrin on parietal cell Ihh expression. Recent research done by the Zavros 
laboratory using laser capture microdissection to identify roles might Shh follow in 
gastric cell proliferation and differentiation, showed that the hypergastrinemic 
H+,K+-Cre/Shh-/- mouse had high Ihh gene expression in the pit region of the corpus 
gastric glands32. This upregulation of Ihh in the gastric pit region was corrected 
when the mutant mice were treated with octreotide, a somatostatin analog, which 
inhibits, in addition to other actions, gastrin secretion32. These results suggest that 
high gastrin upregulates Ihh in gastric pit cells. Ihh is understudied in the stomach 
and it will be important to examine the normal localization of Ihh and whether 
gastrin regulates Ihh gene transcription. Last, Zavros et al, in an elegant study, 
discovered the role of gastrin and acid in Shh protein induction, processing, and 
association with tumor formation12. This study aimed to examine whether gastrin 
regulates Shh expression in parietal cells using the gastrin mutant mouse and canine 
parietal cell primary cultures. Both Shh mRNA and protein isoforms were reduced 
in the gastrin mutant stomachs and normalized upon gastrin treatment. To test if 
this induction was acid dependent, canine parietal cells were treated with gastrin or 
omeprazole, and results showed that while the unprocessed 45kD Shh was normal 
in all treated groups, the active 19kD Shh was induced in the gastrin-treated cells, 
but not when gastrin and omeprazole were added together. Lastly, the study 
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showed that pepsin A and unprosseced Shh were highly expressed in human gastric 
tumors compared to normal tissue12. These data suggest: (i) chronic gastrin 
treatment can induce the expression of Shh mRNA and protein; (ii) acid is required 
for the processing of the 45kD Shh to the active 19kD Shh; and (iii) that high 
unprocessed Shh protein and low pepsin A are associated with gastric tumor 
formation. 
1.4.3 HEDGEHOG SIGNALING PATHWAY AND GASTROINTESTINAL CANCER 
Hh signaling has been shown to be important for gastric development74, 75 
and cellular transformation84. Cancerous cells with aberrant Hh signaling can 
develop in different ways. For example, cancers can have constitutively activated Hh 
receptor, with no need of the ligand while others may activate the ligand in 
autocrine, juxatacrine or paracrine fashion85. The analysis of the developing Hh 
mutants as well as the adult Shh mutant HKCre/ShhKO showed transformation of the 
epithelium32, 74, 75. Also, physiologic gastrin, acid and Shh protein processing events 
important for normal gastric homeostasis are found to be disrupted in human 
gastric tumors12. Patients with low gastric acid content and high gastrin have been 
found to have aberrant Shh protein processing, which might be associated with 
gastric cancer development12. Moreover, different human gastric cancer cell lines 
have been found to be responsive to Hh by expressing the Hh responsive gene 
encoding the Ptc receptor, including SNU1, SNU16, AGS and NCI-N8718. All of these 
studies suggest that Hh signaling plays an important role in controlling the mucosal 
cellular content and the structural organization of the stomach. 
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1.5  PARATHYROID HORMONE-LIKE HORMONE (PTHLH) 
Pthlh was first known to be associated with hypercalcemia of malignancy, in 
which tumors increase serum calcium levels by promoting bone and renal tubular 
calcium resorption86. Pthlh was named due to the similarity between the N-
terminus of Pthlh and parathyroid hormone (Pth); 8 of the first 13 amino acids are 
identical and both can bind to the same receptor: parathyroid hormone 1 receptor 
(Pth1r)87, 88. Although the terminology is based on biochemical and structural 
resemblance, Pthlh and Pth are different in many ways: (i) Pthlh has a wide 
temporal-spatial expression profile in the body, while Pth is limited to the 
parathyroid gland and central nervous system89; (ii) Pthlh acts in autocrine, 
paracrine or intracrine fashion under normal physiological conditions, while Pth 
follows endocrine roles89; (iii) While Pth regulates calcium homeostasis via renal 
and skeletal effects, Pthlh has a wide range of functions. It stimulates calcium 
transport in many tissues, relaxes contracted smooth muscles 90 , and regulates 
various cellular events such as proliferation, differentiation and apoptosis88, 89, 91, 92. 
1.5.1 PTHLH GENE STRUCTURE AND TRANSCRIPTION 
The human Pthlh gene consists of eight exons (Figure 1-3). Exon 5 codes the 
“prepro” region of the immature Pthlh protein, while exon 6a encodes the majority 
of the protein. The 5’-untranslated region has three different transcriptional starts: 
P1, P2 and P393-96; P1 and P3 contain a TATA box while P2 contains a GC box97.  
There are distinct 3’-untranslated ends in exons 6b, 7 and 8 that are enriched 
with AU rich elements (ARE), which are important for the half-life of the mRNA. The 
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Figure 1 -  3: Pthlh gene structure. 
The human Pthlh gene consists of 8 exons (untranslated: white boxes, translated: red boxes). The gene has 3 transcriptional 
starts (arrows) preceding exons 1, 3 and 4. Due to alternative splicing (blue lines), the human Pthlh gene can produce 15 
mRNA isoforms, all of which include exons 5 and 6a, but differ in their 5’ or 3’ untranslated regions. Splicing from exon 6a to 
exon 7, 8 and 9 can give mRNAs, which when translated, produce 1-139aa, 1-173 or 1-141, respectively. The mouse Pthlh 
gene consists of 4 exons with one transcriptional start preceding exon1 and one 3’UTR with a single mRNA produced. The 
3’UTR(s) of human and mouse Pthlh genes contain many AU-rich elements (ARE, vertical lines on the-3’UTR). 
Exon: 
Exon: 
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ARE motifs are targeted by proteins that regulate Pthlh mRNA stability97. By 
alternative splicing, fifteen distinct mRNA isoforms can be formed, and due to the 
diversities in the 3’ ends three initial translation products are formed: (1-139aa), (1-
141aa) and (1-173aa)88. These initial translation products then go through post-
translational cleavages by prohormone convertase enzymes, and as a result a family 
of mature secretory peptides is formed, each peptide with its own physiological 
function87, 88 (Figure 1-4). 
 Pthlh is highly conserved between species, with the human and mouse 
peptide sequences differing by only 3aa among the first 111aa88. Both mouse and rat 
genes have exons equivalent to the human exons 4, 5,6a and 8, although they differ 
in producing only one mRNA product (Figure 1-3). Also, the mouse and rat genes 
have one promoter which is equivalent to the human P3 transcriptional start site. 
There is some evidence that homology exists between human Pthlh and rodent 
Pthlh over the P2 and exon 3 of the human gene, but not exons 1 and 287, 98. 
1.5.2 PTHLH BIOACTIVE PROTEINS 
Pthlh complexity is not limited to its gene structure or gene transcription, but 
it also extends to the variety of bioactive proteins that are formed97. In human, there 
are 3 initial post-translational products: 1-139 aa, 1-141 aa and 1-173 aa, each 
having different carboxyl-termini due to the alternative splicing of Pthlh gene 
transcription. The first 139aa are identical among the 3 initial products, and any 
proteins with amino acids sequences located between +140 and +173 are 
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considered unique, and to date there are no identified functional peptides resulted 
from the processing of the carboxyl-termini of 1-141aa or 1-173aa (Figure 1-4). 
 These immature peptides are preceded by 36 amino acids known to carry 
signal peptide and putative propeptide sequences. The signal peptidase enzyme 
cleaves this sequence in order to transfer Pthlh from the endoplasmic reticulum to 
the cytoplasm. The remaining sequence is thought to be cleaved at a dibasic motif 
located just before the first amino acid located at the position +197. 
The immature peptides then undergo further processing by prohormone 
covertase processing enzymes97. This is because of the enrichment of immature 
Pthlh peptides by mono-, di- and tetra-basic amino acids sequences (lysine and 
arginine), which are usually targeted by the processing enzymes; thus, leading to the 
production of mature peptides. 
The identities of these of these prohormone processing enzymes are not 
completely known, however; there are several studies suggesting the expression of 
both Pthlh and the subtilisin family, which normally target dibasic and tetrabasic 
residues, in the same cells99, 100. 
To date, only 3 bioactive Pthlh peptides have been identified as listed below:  
I. Pth-like  
This peptide is the most studied compared to the other Pthlh peptides. The 
first 13 aa are identical to the parathyroid hormone (Pth), and although the peptide 
sequence between (14-36) is different than in Pth, it results in a structure similar to
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Figure 1 -  4: Pthlh functional domains and post-translational processing products 
A, Functional domains of Pthlh among human and rodents includes a signal peptide (SP), a pro-peptide (Pro) and both 
together consume 36 amino acids preceding the immature Pthlh initial product(s). The peptide sequence between +37 to 
+111(rainbow shaded) is highly conserved among different species97. However, and only in human, peptides with 
sequences located between +140 and +173 are unique and with unknown function(s). Pthlh peptide is enriched with basic 
amino acids which normally are processing targets for the signal peptidase (green arrow) and prohormone convertase 
enzymes (black arrows).B, Secretory forms of Pthlh that have been identified include: Pth-like, mid-region and the 
osteostatin Pthlh peptide. Both synthetic (107-111)aa and (107-139)aa had similar effect, thus the osteostatin protein had 
dashed carboxyl-terminus in the diagram (see text).    
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 Pth and requiered for the binding of the Pth-like peptide to the receptor (Pth1r)97. 
This peptide is known to act as a key bone resorption-enhancing factor101, smooth 
muscle relaxant 102, 103,  and inducer of proliferation99 and differentiation in several 
tissues91. The arginine located at +37 is considered a cleavage site for a monobasic 
prohormone cleaving enzyme, although the identity of this enzyme is unknown.  
II. Mid-region  
  This peptide has generated recent interest for several reasons. The mid-
region peptide was first found to play a role in placental calcium transport104. In 
addition, accumulating studies suggested the involvement of this peptide in the 
cellular death, proliferation, toxicity and invasiveness of human breast cancer cell 
lines105.  Although this peptide has been suggested to have multiple functions, the 
receptor of this peptide has yet to be identified.  
At the biochemical level, this peptide is considered unique. It is rich with 
multiple basic sites located at the positions +88 and +106 which serves as (i) 
processing sites for different mid-region peptides (Figure 1-4),  and a (ii) nuclear 
localization signal106. There is evidence suggesting the nuclear localization106 and 
the binding of Pthlh to chromatin107; however the precise role and mechanism of 
this action is not clearly understood. 
III. Carboxyl-terminal  
Due to the presence of the presumed processing protease cleavage site at 
amino acids (102-106) and because of the high evolutionary conservation of the 
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peptide sequence (107-111) among human, rodent and chicken Pthlh, Fenton et al 
tested the effects of the synthetic Pthlh (107-111) and ( 107-139) on bone cells in 
vitro108, 109. These 2 peptides showed potent inhibition of osteoclastic bone 
resorption108, 109 ,but not the hPth (1-34)aa which resembles the Pthlh (1-36) in 
effect108. The (107-111) aa peptide named osteostatin109 has been shown to play a 
role in keratinocyte cell cycle110. Like the mid-region Pthlh, the receptor of this 
peptide is not yet identified. 
1.5.3 PTHLH GENE EXPRESSION IN THE STOMACH 
Cellular localization and regulation of Pthlh in the stomach is poorly 
understood. This is in part because of: (i) low steady-state cellular levels of Pthlh, 
(ii) and short Pthlh mRNA half-life caused by the numerous AREs located in the 
3’UTR(s)111. Previous studies that analyzed Pthlh mRNA expression in various 
tissues by RT-PCR showed highest expression in stomach112,  and other studies 
implied Pthlh expression in gastric mesenchyme103 by immunohistochemistry, 
gastric gland isthmus region by in situ hybridization and immunohistochemistry, 
ECL cells by immunohistochemistry and microarray analysis113, 114 and parietal cells 
by microarray analyses6, 16. The conclusions, regard Pthlh gastric expression 
between those studies, were conflicting. Thus, the creation of the PthlhLac Z/+ 
reporter mouse was advantageous, especially that the transgenic design eliminated 
the ARE regions, eliminating short mRNA half-life. The gastric expression, however, 
was not described111. Chapters 2 and 3 address Pthlh localization in mature and 
developing stomach, respectively. 
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1.5.4 REGULATION OF PTHLH BY THE HEDGEHOG PATHWAY 
Pthlh is well studied in endochondral bone development due to its 
importance in bone morphogenesis and growth115, 116. Pthlh115 and the parathyroid 
hormone receptor (Pth1r)116-deficient embryos are small in size with short limbs. 
Also, they have domed skulls, short snouts and mandible-protruding tongues.  These 
studies explained the short limbs to the role of Pthlh in delaying the movement of 
chondrocytes from proliferation to differentiation zones115, 116. Although many 
studies suggested the association between Hh signaling80, 117-120 and Pthlh gene 
regulation and endochondral bone formation, whether Hh directly activates Pthlh 
has not yet been shown. Early studies found that treating embryonic mouse bone 
explants with Shh induced Pthlh expression, as well as delayed chondrocyte 
differentiation115, 116. Furthermore, Shh pretreatment for either Pthlh or Pth1r–
deficient bones did not rescue the premature chondrocyte differentiation115, 116. 
These studies suggested that Hh regulates Pthlh expression. Chapter 4 of this thesis 
will address whether Hh regulates gastric Pthlh expression.  
1.5.5 PTHLH FUNCTION IN STOMACH 
The function of Pthlh in the stomach is poorly studied. This could be due to: 
(i) the Pthlh mutant mouse model is perinatal lethal115, 121; (ii) the amniotic fluid 
surrounding the Pthlh null embryos during development is rich in Pthlh122; (iii) and 
if the mutants were not lethal, there will be another challenge in which the mother’s 
milk has high levels of Pthlh. Pthlh concentration in the mother’s milk is 100,000 
times higher than the physiological body serum concentration123. These facts imply 
the central role of Pthlh in development. One way to study Pthlh function is by 
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examining the Pth1r mutants. The Pth1r embryos die between E9.5 and E18.5, 
depending on the mouse genetic background116. Studies done on bone development, 
which is the most studied organ, showed similar phenotypes in both Pthlh and Pth1r 
mutants, but it was more severe in the Pth1r mutant116. Pth1r mutants were smaller 
in size compared to Pthlh mutants, most likely due to the effect of maternal Pthlh 
which is complementing the absence of Pthlh in the Pthlh mutants but not in the 
Pth1r mutants116 .  
There are few studies which have suggested the importance of Pthlh in 
gastric smooth muscle relaxation. Ito et al.103 examined the effect of Pthlh on rat 
gastric stress-induced hyper-contraction, which used a water immersion stress 
model103. Pthlh inhibited gastric muscle contraction and Pthlh mRNA expression, 
but induced Pth1r expression. This suggests that Pthlh induces gastric relaxation103.  
Possible roles of gastric Pthlh in gastric gland proliferation and differentiation is to 
be analysed. 
1.5.6 PTHLH ASSOCIATION WITH GASTRIC CANCER 
Aberrant Pthlh expression has been observed in different human cancers124-
126. Increased levels of Pthlh expression in skeletal metastasis of human breast 
cancer120 and in advanced stages of prostate cancers suggest the involvement of 
Pthlh in tumor proliferation and progression 127. Gastric cancer is a major cause of 
cancer death worldwide, and the most common malignant disease in Japan128. 
Several studies showed that Pthlh is highly expressed in gastric tumors99, 128-134. 
Although it is controversial whether increased Pthlh expression is associated with 
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hypercalcemia129-131, 135, 136, it can be concluded from research on gastric cancer and 
its relation with Pthlh that: (i) high Pthlh serum is associated with adverse 
prognosis (reduced survival)99, 132, 135, 136,133 (ii) strong Pthlh expression has been 
recognized in both poorly differentiated gastric tumor samples129, 130, 132, 133 and 
human gastric cancer cell lines99, 128, 129; (iii) high Pthlh is associated with high 
prohormone convertase enzyme expression99 which is important for the processing 
of the immature Pthlh protein; and (iv) gastric tumors with heterotopic ossification 
were also highly positive for Pthlh expression134 .  The mechanism behind the 
aggressive role of Pthlh in gastric transformation is not yet known.  
1.6 THESIS OVERVIEW 
This thesis project aimed to describe the novel growth factor Pthlh in the 
stomach in three different areas: (i) defining the normal expression of Pthlh in the 
developing as well as the adult stomach; (ii) examining the function of Pthlh in the 
developing stomach; (iii) investigating the regulation of Pthlh gene expression in the 
stomach. 
Chapter 2 investigates the regulation of Pthlh gene expression in the stomach 
by the hormone gastrin. Although there are numerous studies that indicate a 
potential proliferation effect of gastrin in normal and diseased stomachs, the 
mechanism is unknown. In this chapter, I used in vivo and in vitro models to explore 
gastrin regulation of Pthlh gene expression. I found that Pthlh is regulated by 
gastrin, with the observation of a significant reduction in Pthlh expression in 
gastrin-deficient mice. Additionally, wild-type mice that were acutely treated with 
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gastrin showed a rapid and transient induction of Pthlh gene expression. By 
analyzing different human gastric cancer cell lines, I found that the induction of 
Pthlh expression by gastrin occurs through the gastrin receptor Cckbr. Also, I 
screened different Pthlh mRNA isoforms found in the normal human stomach. 
Likewise, I identified Pthlh mRNA species induced by gastrin in the human gastric 
cancer cell line AGS-E which expresses the gastrin receptor Cckbr. Most importantly, 
my data indicate that the regulation of Pthlh by gastrin is at a post-transcriptional 
level by regulation of mRNA half-life. 
 Chapter 3 focuses on studying the function of Pthlh in the stomach. I 
examined the function of Pthlh in the embryonic stomach at E18.5 by taking 
advantage of the null mutation gene in homozygous Pthlh-LacZ embryos111 . I did 
not detect significant differences in Pthlh gene expression in the Pthlh mutant 
embryonic stomach, possibly due to the compensational effect of the maternal Pthlh 
found in the mother’s amniotic fluid. The heterozygous mice were used to follow 
Pthlh expression in the stomach by following the LacZ knock in reporter 
expression111. My results demonstrate that Pthlh is uniquely expressed in the acid 
secretory parietal cell of the mature mouse stomach (chapter 2), and in the 
squamous epithelial cells of the E18.5 mouse forestomach.  
 Chapter 4 studied the regulation of Pthlh gene expression by the Hh signaling 
pathway. The Hh/Pthlh signaling pathway, although not completely defined, has 
been well-studied in bone morphogenesis. Additionally, aberrant Pthlh expression 
and Hh signaling have been reported in human gastric cancer. Moreover, mice 
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treated chronically with gastrin display high Shh expression. Based on those studies, 
I hypothesized that Hh mediates the induction of Pthlh expression by gastrin. My 
data, however, contradicted this hypothesis. Gene expression of Hh signaling 
pathway components was not changed during acute gastrin treatment of wild-type 
mice, as was seen with Pthlh gene expression. Moreover, analysis of the embryonic 
stomachs of H+,K+-Cre/Shh-/-, Gli2 and Gli3 mutants did not show changes in Pthlh 
gene expression. Together, these data suggest that: (i) Hh is not mediating the 
transient induction of Pthlh expression by gastrin, and (ii) that the Hh pathway 
members Shh, Gli2 and Gli3 are not required for Pthlh expression. 
 Chapter 5 summarized the overall findings and underwent remaining 
questions with suggestions for possible future analyses can be performed to 
understand Pthlh role in normal and diseased stomach. 
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CHAPTER 2 
GASTRIN REGULATION OF PARATHYROID HORMONE-LIKE HORMONE 
(PTHLH) IN PARIETAL CELLS 
2.1 ABSTRACT 
 Parietal cells play a fundamental role in stomach maintenance, not only by 
creating a pathogen free environment through the production of gastric acid, but 
also by secreting essential growth factors thought to be important for homeostasis 
of the gastric glands. The gastrointestinal hormone gastrin is known to be a critical 
regulator of parietal cell function as well as proliferation and differentiation of the 
gastric glands.  Our previous gene expression microarray studies of mouse stomach 
mucosa identified parathyroid hormone-like hormone (Pthlh) as a potential new 
gastric growth factor. Although Pthlh was described to be highly expressed in 
gastric tumors, its normal expression, function and regulation in the stomach are 
unknown. In this study we used pharmacologic and genetic mouse models as well as 
human gastric cancer cell lines to determine the cellular localization and regulation 
of this growth factor by the hormone gastrin. Analysis of PthlhLacZ/+ knock-in 
reporter mice localized Pthlh to parietal cells in the gastric corpus. Gastrin 
regulation was demonstrated by increased Pthlh mRNA abundance after acute 
gastrin administration and by reduced Pthlh expression in gastrin-deficient mice.  
51 
 
To examine the mechanism, we treated human gastric AGS-E cells with gastrin, 
observing a robust induction of endogenous Pthlh mRNA within 2 hours. 
Pharmacologic inhibitor studies demonstrated that PI3K, PKCα, Erk1/2 and P38 
MAPK signaling were required for this induction. Analysis of mRNA half-life showed 
that gastrin stabilized the Pthlh transcripts. Furthermore, gastrin induced numerous 
Pthlh mRNA isoforms, including those from different promoters.  
2.2 INTRODUCTION 
 Gastrin is known as the physiologic stimulator of gastric acid secretion1.  
When a meal is ingested, gastrin is released to the blood stream from endocrine 
cells in the distal stomach (antrum) to target the proximal glandular mucosa 
(corpus) and stimulate gastric acid secretion1. In the corpus, both the acid-secreting 
parietal cells and the histamine-secreting enterochromaffin-like (ECL) cells are the 
only cells known to express the gastrin receptor (Cckbr)1 and thus respond directly 
to gastrin.  
 In addition to its central role in acid stimulation, gastrin is well known to act 
as a growth factor to stimulate gastric epithelial cell proliferation2-9. A single 
injection of pentagastrin, a synthetic form of gastrin peptide, into rats increased the 
total amount of corpus mRNA, protein and DNA consistent with stimulation of 
cellular division 10. Moreover, hypergastrinemic human conditions11 and mouse 
models12 commonly exhibit gastric hyperplasia, although the mechanism is 
unknown.  
Parietal cells acid secretion is essential in creating a gastric pathogen free 
environment, and therefore preserves a healthy gastric cellular integrity. It is 
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equally important to note that several proteins, thought to be important for 
homeostasis of the gastric gland, are expressed by parietal cells. These proteins 
include: (a) morphogens like sonic hedgehog (Shh)13 and Indian hedgehog (Ihh)14, 15, 
(b) signaling pathway regulators like the insulin-like growth factor binding protein 
2 (Igfbp2)16 and the secreted form of growth hormone receptor which acts as GH 
binding protein (GHR)16 and (c) growth factors such as  vascular endothelial growth 
factor B (Vegfb)16, and parathyroid hormone-like hormone (Pthlh)15, 16.  
 The growth factor Pthlh is broadly expressed in numerous tissues during 
development and adulthood, orchestrating key cellular events, such as cell 
proliferation and differentiation17.  Unsurprisingly, imbalanced Pthlh gene 
regulation has been frequently observed in human cancers18, including stomach 
cancer19-22.  Although the normal function and gene regulation of Pthlh is well 
studied in some tissues (for example, bone and mammary17), very little is known 
about the physiologic role and the regulation of Pthlh in the stomach. One study 
suggested the importance of Pthlh in promoting gastric smooth muscle relaxation23, 
however the mechanism behind this process as well as whether Pthlh has other 
functions in the stomach are unknown. 
This chapter investigates the normal gastric expression of Pthlh in the 
stomach. It also describes the regulation of Pthlh gene expression by gastrin. 
2.3 MATERIAL AND METHODS 
Mice 
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PthlhLacZ/+ 24 and gastrin-deficient25 mice were on mixed CD-1 and C57BL/6 
strain backgrounds, respectively. Mice were housed in ventilated and automated-
watering cages under specific pathogen-free conditions. All animal procedures have 
been approved by the University of Michigan Committee on Use and Care of 
Animals. For all experiments, 1-4 month-old mice from both genders were used. 
Gastrin Stimulation 
Wild type mice were fasted overnight with free access to water before i.p. 
injection with vehicle (150 mM NaCl, pH 7) or 250µg/kg human gastrin I (Bachem) 
for 1, 2 or 4 hours before stomach collection for analysis.  
Cells and Pharmacological Inhibitors 
AGS-E human gastric cancer cell line stably transfected with the human Cckb 
receptor were obtained from Timothy Wang (Columbia University)26. Cells were 
cultured in DMEM (Invitrogen) containing 10% fetal calf serum, 100 IU/mL 
penicillin, 100 µg/mL streptomycin, 0.292 mg/mL L-glutamine and 2mM sodium 
pyruvate (Invitrogen), and grown at 37˚C with 5% CO2. Puromycin (0.02mg/mL) 
was used occasionally during regular culture to maintain the Cckbr expressing 
construct in these cells. Unless otherwise mentioned, cells were seeded at 3x105 
cells /well in 6-well plates overnight, serum-starved for 24 hours, and then treated 
for 4 hours with serum-free media containing vehicle or 10-7M human gastrin. For 
Cckbr signaling experiments, cells were pre-treated 30 minutes before gastrin 
treatment with Cckbr pathway inhibitors: SB203580 (10-5 M), Ro-32-0432 (10-6 M), 
LY294002 (1.5x10-5 M), or AG 1478 (9x10-6 M) (Calbiochem), or PD98059 (5x10-7 
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M, Cell Signaling). Human gastric cell lines AGS and NCI-N87 were obtained from the 
American Type Culture Collection (ATCC # CRL-1739™ and CRL-5822™, 
respectively). MKN-45 (Riken, Japan) and 23132/87 cells were obtained from 
(DSMZ, Germany). AGS cells were cultured similarly as AGS-E cells. All other cell 
lines were cultured in RPMI-1640 media as recommended by the source. 
Whole Mount X-gal Staining 
The protocol previously described27 for whole-mount X-gal staining was 
modified. Briefly, stomachs from PthlhLacZ/+ mice were opened along the greater 
curvature, pinned flat on dental wax and fixed for 1 hour in 4% paraformaldehyde 
(PFA) in PBS. Tissues were washed 3 times (15 minutes) in X-gal wash buffer (0.1 M 
sodium phosphate pH 7.3 containing 2 mM MgCl2 and 0.02% NP-40) and placed 
between 5 hours to overnight in X-gal (5-bromo-4-chloro-3-indyl-β-D-galactosidase; 
Roche) staining solution (1mg/mL X-gal in N,N dimethylformamide, 5mM 
K3Fe(CN)6, 5mM K4Fe(CN)6-3H2O) in X-gal wash buffer) at 37°C, protected from 
light. Tissue was washed in X-gal buffer and analyzed for LacZ expression.  
Immunohistochemistry 
Stomach cryosections (8µm) were dried at room temperature for 5 minutes, 
and then rinsed with 0.01% triton X-100 in PBS (TPBS). Sections were blocked with 
10% goat serum in 0.1% TPBS for 30 minutes then stained with rabbit anti β-
galactosidase (1:1000, gift from J. D. Engel, University of Michigan) overnight at 4˚C. 
Slides were rinsed in 0.01% TPBS and incubated for 1 hour at room temperature 
with mouse monoclonal antibody against H+, K+- ATPase-α subunit (1:500, Medical 
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and Biological Laboratories, Nagoya). After washing in 0.01% TPBS, samples were 
incubated with appropriate secondary antibodies conjugated to Cy2 or Cy3 (1:200, 
1:500, respectively, Jackson ImmunoResearch Laboratories, West Grove). Sections 
were mounted with ProLong Gold anti-fade reagent with 4', 6-diamidino-2-
phenylindole DAPI (Invitrogen). Fluorescence images were captured with a cool 
snap digital camera mounted on a Nikon E800 upright fluorescence microscope. 
RNA Isolation and Gene Expression Analysis 
RNA was isolated from mouse stomachs or from cultured cells using TRIzol® 
(Invitrogen), as described15. Isolated RNA was purified and DNase-treated using the 
RNeasy Mini kit (Qiagen). 1µg RNA was reverse-transcribed using the iScript™ cDNA 
synthesis kit (Bio-Rad), as recommended by the manufacturer. Gene expression was 
measured using quantitative reverse transcription-PCR (qRT-PCR) analysis as 
described 15 using the primers listed in (Table 2-1). Expression levels were 
determined for individual samples (in triplicate) and normalized to the expression 
of glyceraldhyde 3-phosphate dehydrogenase (Gapdh) , which did not differ in 
control and experimental groups. 
RT-PCR Analysis of Pthlh Isoforms 
Pthlh gene structure (Figure 2-5, A) was drawn using GenePalette software28. 
Normal human gastric RNA samples were purchased (Origene, Zyagen and Cell 
Applications, Inc.) and 1µg was transcribed using the IScript™ cDNA synthesis kit. 
PCR used the Go Taq Flexi DNA Polymerase kit (Promega). Primer sequences,  
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Table 2 - 1 : Oligonucleotid primers(5’ to3’) for quantitative reverse transcription polymerase chain reaction 
Species Gene Forward  Reverse  Amplicon (bp) 
Human 
Gapdh GAGTCCACTGGCGTCTTCACC GAGGCATTGCTGATGATCTTGAGG 164 
Pthlh GGTGTTCCTGCTGAGCTACGC TCGTCGCCGTAAATCTTGGATGG 136 
TFF2 TAACAGGACGAACTGCGGCTTC GCACCAGGGCACTTCAAAGATG 244 
     
Mouse 
Gapdh TCAAGAAGGTGGTGAAGCAGG TATTATGGGGGTCTGGGATGG  350 
Pthlh GACGTACAAAGAACAGCCACTCA TTTTTCTCCTGTTCTCTGCGT TT 81 
HK-α TGTACACATGAGAGTCCCCTT G GAGTCTTCTCGTTTTCCACACC 157 
HK-β AAC AGA ATT GTC AAG TTC CTC AGA CTG AAG GTG CCA TTG 140 
Pth1r AAG TGG TGG CAG TAC CTT GTC GTCC CCC GTT CCC GAG TCT CAT TGG 171 
Gastrin GGACCAGGGACCAATGAGG CCAAAGTCCATCCATCCGTAGG 173 
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product content, product size, as well as conditions used to amplify each Pthlh 
isoform are shown in (Tables 2-2 and 2-3). Reaction mixtures (50 µl) contained 0.2 
µM of each forward and reverse primer, 0.2 mM dNTP, 1X reaction buffer, 2mM 
MgCl2 and 0.05 units of Taq polymerase. Betaine29 (1M, Sigma) was used in PCR 
reactions that amplified the P3 Pthlh isoform. Amplification was performed with 35 
cycles of denaturation at 95˚ C for 30 seconds, annealing at 55˚ or 60˚ C (Table 2-3) 
for 20 seconds and extending at 72˚C for 45 seconds. PCR products were run on a 
1.7% agarose gel to evaluate mRNA isoforms. Amplicons were sequenced to validate 
the specificity of the different assays for different Pthlh isoforms.  
Measurement of Pthlh mRNA Half-Life  
AGS-E cells (106) were grown overnight, then treated with vehicle or 10-7 M 
gastrin for 4 hours. Actinomycin D (10µg/mL DMSO, Sigma) to inhibit mRNA 
synthesis was added to the media and samples collected at 0, 2, 4, 8, 12 hours for 
RNA isolation. qRT-PCR values of Pthlh mRNA at each time point were normalized 
to Gapdh and compared to values at time 0.  
Statistics 
Data are presented as mean ± SEM and analyzed by student’s t-test or one way 
ANOVA (Graph Pad Prism) followed by Tukey post test. P < 0.05 was considered 
significant. 
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Table 2 - 2 : Oligonucleotid primers for reverse 
transcription polymerase chain reaction 
 
Primer  Primer Sequence 5'-3' 
F1 AGGTACCTGCTTTCTAATA 
F3 TTCTCCGGCAGGTTTG 
F4 CCACGAACCCAGGAGAACTGC 
F5 GGAGACGATGCAGCGGAGAC 
R6a TTTCCTGCTCCTTGCGTTTCC 
R6b TTGCCCAGGTGTGAGAGTAAGG 
R7 GGCAATAAAGTAGGGTCC 
R8 CCAATGTGCAGTTTCATAGAGC 
Pth1r F GGCGTCCCTCACCGTAGC 
Pth1r R AGAGTAGAGCACAGCGTCCTTG 
Gapdh F GAGTCCACTGGCGTCTTCACC 
Gapdh R GAGGCATTGCTGATGATCTTGAGG 
 
The first 8 primers are for human Pthlh gene 
with F = forward, R = reverse and a number 
indicating Pthlh specific exon (see Figure 2 – 5). 
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  Table 2 - 3 : Conditions and product size of each primers sets used to identify distinct pthlh 
transcripts by RT-PCR analyses 
Transcript  Primer Set Recognized Exons Product Size (bp) Annealing Temperature (C°) 
All F5-R6a E5-E6a 419 
55° 
P1 
F1-R6a 
E1-E2-E3-E5-E6a 915 
P1' E1-E3-E5-E6a 858 
P1" E1-E5-E6a 615 
P2 F3-R6a E3-E5-E6a 693 
P3 F4-R6a E4-E5-E6a 648 
3'UTRa F5-R6b E5-E6a-E6b 901 
60° 3'UTRb F5-R7 E5-E6a-E7 981 
3'UTRc F5-R8 E5-E6a-E8 691 
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2.4 RESULTS 
Pthlh is Expressed in Parietal Cells 
To study gastric Pthlh expression, we first measured the endogenous Pthlh 
mRNA abundance by qRT-PCR in wild type mouse stomach. Analyzing tissue strips 
from proximal to distal stomach showed a gradient of expression of Pthlh in the 
glandular part of the stomach, with reduced expression in the direction toward 
antrum (Supplemental Figure 2-1, A and B). Interestingly, the Pthlh pattern of 
expression was consistent with the expression of the parietal cell marker H+, K+-
ATPase α subunit in corpus compared to antrum (Figure 2-1, A and B and 
Supplemental Figure 2-1, B and C). 
 To identify which cells express Pthlh, we utilized PthlhLacZ/+ reporter mice24. 
Whole mount X-gal staining confirmed our qRT-PCR results, with LacZ expression 
restricted to the gastric corpus, in organization similar to the normal distribution 
parietal cell (Figure 2-1, C and D). Immunohistochemical analysis for the PthlhLacZ/+ 
reporter mouse stomach demonstrated co-localization of antibodies for β-
galactosidas and H+, K+-ATPase α, suggesting that Pthlh is localized to parietal 
cells(Figure 2-1, E- G).  
Pthlh is Induced by Gastrin  
Since the hormone gastrin regulates parietal cells15, we examined whether it 
might regulate Pthlh gene expression. Analysis of Pthlh expression in gastrin-
deficient mice, showed a 5-fold reduction in mRNA abundance compared to control 
(Figure 2-2, A). This regulation was also demonstrated by a reduction of PthlhLacZ/+ 
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Figure 2 – 1: Parietal cells express Pthlh.  A) Pthlh and the parietal cell marker 
H+, K+- ATPase α (HK-α) subunit mRNA abundance were measured by 
quantitative reverse transcription-PCR (qRT-PCR). Values were normalized to 
Gapdh as mean ± SEM (N=3-5). B) Whole mount X-gal staining in PthlhLacZ/+ 
reporter mouse stomach showed high LacZ expression near the squamo-
glandular junction compared to none in the wild type mouse (f:forestomach, 
c:corpus and a:antrum). Dark edge staining is an artifact due to pinning the 
tissue. C) Co-immunostaining of adult Pthlh-LacZ stomach cryo-sections with 
antibodies against β-galactosidase (β-gal) (green) and HK-α (red) showed co-
localization in a subset of parietal cells. Arrowhead, β-gal-expressing parietal cell; 
arrow, non-β-gal-expressing parietal cell.  Scale bar=50µm. 
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Figure 2 – 2: Gastrin stimulates Pthlh expression in vivo. A) Pthlh mRNA 
abundance was measured by qRT-PCR analysis of corpus from gastrin-deficient 
mice (Gas-/-) compared to control littermates. Values were normalized to Gapdh 
and data are shown as mean ± SEM (N = 4, *P <0.05). B) Whole mount X-gal 
staining of PthlhLacZ/+ reporter mouse stomach on normal or Gas-/- background. 
Staining at the pylorus is non-specific. C) qRT-PCR for Pthlh mRNA measured in 
corpus isolated from wild type mice 1, 2 or 4 hours after gastrin injection 
(250mg/kg). ***P< 0.001 vs. vehicle injected group. For A and C, data (mean ± 
SEM) are shown in reference to Gapdh expression measured in the same samples 
(N = 4). 
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reporter gene expression observed by X-gal staining (Figure 2-2, B). In addition, 
gastrin treatment of wild type mice demonstrated rapid and transient induction of 
Pthlh expression, which peaked at 1 and 2 hours post injection, returning to basal 
levels by 4 hours (Figure 2-2, C). Together these results demonstrated that gastrin 
can induce Pthlh expression in vivo. 
To study possible mechanisms for this induction, we utilized the human gastric 
cancer cell line AGS-E 26.  Treatment with gastrin for 2, 4, 6 or 12 hours showed a 
robust induction of Pthlh mRNA at all time points in comparison to vehicle (Figure 
2-3 A, left). The highest induction of Pthlh expression (> 150- fold) was observed at 
4 hours post-gastrin treatment. We also examined the response of the TFF2 gene, 
which had previously been shown to be induced by gastrin30. Induction of TFF2 
mRNA expression was delayed and longer-lasting than the pattern for Pthlh (Figure 
2-3, A right). This result suggests that gastrin might follow distinct mechanisms to 
regulate the expression of both genes. These data suggested that gastrin can induce 
Pthlh expression rapidly and transiently. 
To study if Pthlh mRNA induction by gastrin is mediated by the gastrin 
receptor Cckbr, we measured Pthlh gene expression in AGS cells compared to AGS-E, 
which differ in expression of the human Cckbr gene into AGS cells 31. Gastrin 
treatment of AGS cells for 6 hours was not different from vehicle treated cells 
(Figure 2-3, B). In contrast, AGS-E cells exhibited a robust response to gastrin, 
suggesting that gastrin directly stimulates Pthlh expression via the Cckbr receptor.  
 64 
 
  
Figure 2 – 3: Gastrin stimulates Pthlh expression in vitro. A) qRT-PCR 
measurement of Pthlh (left) or TFF2 (right) mRNA abundance in AGS-E cells 
treated with vehicle or gastrin for 0, 2, 4, 6 and 12 hours. *P<0.05, **P<0.005, 
***P ≤ 0.0005 vs. vehicle-treated group of the same time point. B) qRT-PCR 
measurement of Pthlh mRNA abundance in AGS cells, which do not express the 
gastrin receptor Cckbr, or AGS-E cells after 6 hours treatment with gastrin. ***P ≤ 
0.0005 vs. vehicle-treated group of each cell line. All data (mean ± SEM) are 
shown in reference to Gapdh expression measured in the same samples (N = 3). 
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Our earlier results showed that Pthlh is expressed by parietal cells (Figure 2-1, 
C). We wanted to test if the ECL cells express any Pthlh because Cckbr is also 
expressed in ECL cells. Immunohistochemical analysis for PthlhLacZ/+ mouse stomach 
showed no co-localization between the pan-endocrine marker chromogranin A and 
β-galactosidase, suggesting that the Pthlh gene is not expressed in ECL cells 
(Supplemental Figure 2-2). 
Gastrin stimulates the transcription of several genes by means of acid-
dependent or acid-independent pathways32, 33. Based on that, we tested whether 
acid mediates the induction of Pthlh by gastrin by analysis of mice treated with the 
proton pump inhibitor omeprazole. This analysis showed that Pthlh mRNA 
abundance was not changed in the omeprazole treated mice, suggesting that gastrin 
induction of Pthlh gene expression is acid-independent (Supplemental Figure 2-3). 
Intracellular Signaling Pathways Mediating Gastrin Regulation of Pthlh 
Cckbr stimulation is known to activate several downstream signaling pathways 
including the MAPK Erk1/2, MAPK p38, PI3K, PKCα and EGFR34. Pre-treatment of 
AGS-E cells with pharmacologic inhibitors for Erk1/2, p38, PI3K or PKCα blocked 
gastrin induction of Pthlh mRNA expression (Figure 2-4, A-D). In contrast, the EGFR 
inhibitor only partially blocked the response (Figure2-4, E). These results suggest 
that Erk1/2, p38, PI3K and PKCα mediate Pthlh mRNA induction by gastrin and that 
EGFR signaling has limited control on Pthlh expression activation. 
Gastrin Induces Several Distinct Pthlh mRNA Isoforms 
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Figure 2 – 4: Cckbr signaling pathways mediate Pthlh mRNA induction by 
gastrin. qRT-PCR measurement of Pthlh mRNA abundance in vehicle, gastrin, 
Cckbr inhibitor or gastrin and Cckbr inhibitor.  Values were normalized to Gapdh 
and data are shown as mean ± SEM, ** P <0.01, *** P < 0.001. (N=3). 
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It is known that the human Pthlh gene expresses many different Pthlh mRNA 
isoforms (Figure2-5, A)35. Extensive alternative splicing of Pthlh gene can give rise 
to mRNA species with differing 5’ and 3’ UTRs, that all express exons 5 and 6a. 
Because of this complexity, we wanted to know the normal expression of Pthlh 
mRNA isoforms in human stomach and to identify which Pthlh mRNA isoforms were 
regulated by gastrin in AGS-E cells. Thus, RNAs from normal human stomach and 
vehicle or gastrin-treated AGS-E cells were studied (Figure2-5, B). Using RT-PCR 
analysis, normal human samples were found to express Pthlh transcripts specific to 
the promoters P2, P3 but not P1 as well as to the 3’UTR a and c but not b. Analysis of 
AGS-E cells after gastrin treatment showed that all regions were induced, including 
P1, P1’, P2 and P3, as well as 3’UTR regions a, b and c (Figure2-5, B). Interestingly, 
regions specific for P1 were highly amplified when AGS-E cells were gastrin treated 
compared to P2 and P3.  
Given that Pthlh expression has been described to be highly expressed in 
gastric cancers, we next screened several human gastric cancer cell lines for Pthlh 
isoform expression.  The human cervical cancer cell line HeLa was used as a positive 
control for most RT-PCR assays (Figure 2-5, C). NCI-N87, MKN-45 and 23132/87 
gastric cell lines expressed the common Pthlh region with lower expression in 
23132/78 cells. Analysis of Pthlh isoforms expression showed a similar pattern as 
normal stomach, with transcripts resulted from the activation of P2, P3 and/or 
containing the regions from the 3’UTRa and 3’UTRc. These studies show that Pthlh 
is expressed in normal human stomach and human gastric cancer   
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Figure 2 – 5: Gastrin induces different Pthlh mRNA isoforms. A) Diagram of 
human Pthlh gene structure. The Pthlh gene consists of eight exons 
(untranslated, white, translated, black) with three transcription starts (P1, P2 
and P3). Alternative splicing gives rise to isoforms with different 3’ untranslated 
regions: 3’UTR a, b and c. Primer sets were designed to amplify Pthlh mRNA 
species containing P1, P2, P3 and the 3’UTRs a, b or c regions (see Supplemental 
Tables 1 and 2). B) RT-PCR products for samples from normal human stomach 
samples H1, H2 and H3 as well as vehicle or gastrin-treated AGS-E cells. C) RT-
PCR products for different human gastric cancer cell lines. HeLa cells were used 
as a positive control. 
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cells. Gastrin induction of Pthlh was not observed in other human cell lines, 
presumably because they do not express Cckbr (data not shown). 
Gastrin Stabilizes Pthlh mRNA 
Since our results showed rapid induction of Pthlh expression by gastrin 
(Figure 2-3, A), and because the Pthlh 3’UTRs are enriched with AU-rich elements 
(ARE)35, we hypothesized that gastrin acts by stabilizing Pthlh mRNA. To test this 
hypothesis, Pthlh mRNA half-life was measured in AGS-E cells treated with vehicle 
or gastrin in the presence of actinomycin D for 0, 2, 4, 8 and 12 hours (Figure2-6). 
We found that gastrin increased the half-life of Pthlh mRNA from 66 minutes in 
vehicle-treated cells to 144 minutes in gastrin treated-cells. This result confirms 
that gastrin regulates Pthlh gene expression at the post-transcriptional level. 
2.5 DISCUSSION 
This study described the normal pattern of expression of the novel gastric 
growth factor Pthlh by taking advantage of a genetically engineered mouse model in 
which the bacterial β-galactosidase reporter gene (LacZ) was inserted into the 
endogenous Pthlh locus24. The reporter is expressed from the endogenous Pthlh 
promoter and shown to be an accurate readout of gene expression36.  In addition, 
the LacZ insertion creates a mutant allele and homozygous PthlhLacZ/LacZ mice are 
nulls (discussed in Chapter 3). By analyzing the PthlhLacZ/+ mouse, we demonstrated 
that Pthlh expression is specific to parietal cells in the stomach. Interestingly not all 
of the parietal cells expressed the reporter gene, with expression most prevalent in  
 70 
 
  
Figure 2 – 6: Gastrin stabilizes Pthlh mRNA. Exponential curve for remaining 
Pthlh mRNA measurements of AGS-E cells treated with vehicle or gastrin by qRT-
PCR analysis. Cells were collected at 0, 2, 4, 8 and 12 hours after actinomycin D 
treatment. 
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parietal cells in the proximal glandular region, close to the squamous epithelium. 
This pattern of increased expression of other genes or cellular markers, especially in 
the first few glands of the proximal corpus, has been reported13, 37. For example the 
newly discovered gastric tuft cell marker doublecortin-like kinase 1 (DCLK1)37 as 
well as the sonic hedgehog (Shh) growth factor13 were found to be highly expressed 
in this area. How this pattern of gene expression is important to stomach 
homeostasis is yet to be identified.  
Parietal cells have been hypothesized to mediate the proliferating effect of 
gastrin in the stomach for several reasons. First, besides the ECL cell, the parietal 
cell is known to directly respond to gastrin via the Cckbr.  Second, the parietal cell 
expresses several key gastric proteins that have been described in other tissues to 
regulate cellular proliferation or growth, including Sonic hedgehog (Shh)13, Indian 
hedgehog (Ihh) 15, vascular endothelial growth factor B (Vegfb) 15, 16, low molecular 
weight GH receptor which acts as GH binding protein (GHR)16 and insulin-like 
growth factor binding protein 2 (Igfbp2)15, 16. Lastly, gastrin receptors have not been 
defined on gastric progenitor cells, thus suggesting the proliferation effect is 
indirect. The discovery of Pthlh being expressed specifically by the parietal cell in 
addition to the induction of Pthlh expression by gastrin, are supportive facts to the 
commonly accepted hypothesis of parietal cells mediating the proliferative effect of 
gastrin in the stomach.  
In this study we used both in vivo and in vitro systems to demonstrate that 
acute gastrin treatment induces Pthlh gene expression. Pthlh induction is rapid and 
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transient. Also, although different mRNA isoforms were induced by gastrin, isoforms 
with the P1 transcriptional start were pronounced compared to P2 and P3 (Figure 
2-5, B). Based on the literature there is no clear explanation of the differential usage 
of Pthlh promoters, especially those studies that relied on cell lines. However, 
similar to my observations, some studies have confirmed the marked activation of 
the three promoters in human lung and/or breast tumors compared to normal 
cells18, 38.   It will be important to identify which transcription factors might 
contribute to Pthlh expression in the stomach. A recent study in the C4-2 human 
prostate cancer cell line suggested regulation of Pthlh expression is mediated by the 
potential vitamin D response element (nVDRE) located at P1 promoter39. Whether 
similar regulation occurs in parietal cells upon gastrin stimulation is yet to be 
explored.  
Pthlh 3’UTRs contain numerous AU-rich elements (ARE), which have been 
demonstrated to regulate Pthlh mRNA stabilization in human renal carcinoma cell 
lines40. The rapid and transient nature of Pthlh induction by gastrin suggested a 
similar mechanism in effect to increase Pthlh mRNA abundance in the stomach. Our 
results confirm that the mechanism of gastrin induction of Pthlh expression is at 
least in part due to the increased Pthlh mRNA half-life after gastrin treatment.  Other 
studies have described ARE binding proteins that can function to stabilize Pthlh 
mRNA, including HuR, or AUF1 binding proteins40-42.   The identity of ARE binding 
proteins involved in gastrin stabilization was not determined. However, a previous 
study had demonstrated that gastrin stabilizes interlukin-8 (IL-8) and cyclo-
 73 
 
oxygenase 2 (COX-2) mRNAs, which contain AREs, via the HuR binding protein41; 
thus it is likely that gastrin regulates Pthlh through the same mechanism. 
Although this study establishes Pthlh as a putative gastrin-regulated growth 
factor in the stomach, further studies are required to test whether Pthlh directly 
mediates the proliferative effects of gastrin on the gastric mucosa. It will be 
important to determine whether the Pthlh receptor Pth1r is expressed by the gastric 
progenitor cells. My preliminary results suggest that the receptor is more highly 
expressed in the mesenchymal compartment, but these studies did not exclude 
expression in epithelial cells (data not shown). It will also be interesting to find the 
growth/proliferation outcomes in human gastric cancer cell lines after Pthlh 
treatment. Analysis of Pthlh-deficient mouse mutants will be interesting to uncover 
the functional significance of this novel growth factor in the stomach.  Accordingly 
an analysis of Pthlh null mice is described in Chapter 3.  
Our study shows for the first time that Pthlh is also expressed in normal adult 
human stomach (Figure 2-5). It is unknown, however, if the cellular pattern of Pthlh 
expression in human stomach is similar to the mouse. Pthlh is known to be highly 
expressed in gastric cancer19, 22, 43-45.  Accordingly, my data demonstrated that Pthlh 
is expressed in several human gastric cancer cell lines (Figure 2-5, B and C).  
Overall, this study confirmed the Pthlh expression by parietal cell. It also 
demonstrated the stimulation of Pthlh gene expression by gastrin via post-
transcriptional means. It will be essential to find the normal function of Pthlh 
especially that Pthlh is highly elevated in different cancers. 
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Supplemental Figure 2 – 1: The distribution of Pthlh mRNA and parietal cell 
marker expression is similar. A) Wild type mouse stomach was cut to strips 
where a: forstomach, b: proximal corpus, c: distal corpus, d: transition to antrum 
and e: antrum. (B-E) qRT-PCR analysis of endogenous Pthlh, H+,K+-ATPase β , 
gastrin and Pth1r in each stomach strip described in panel A. Values were 
normalized to Gapdh expression and reported as fold-change relative to 
forestomach. All data (mean ± SEM) are shown in reference to Gapdh expression 
measured in the same samples (N=3). 
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Supplemental Figure 2 – 2: Endocrine cells do not express PthlhLacZ/+. Frozen 
stomach sections from were immunostained for β-gal (red) and the pan-
endocrine cell marker chromogranin A (green, goat polyclonal, 1:100 dilution, 
Santa Cruz). Immunohistochemistry performed as described in Material and 
Methods sections. Scale bar=100 μm. 
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Supplemental Figure 2 – 3: Induction of Pthlh gene expression is acid-independent. 
A) qRT-PCR measurement of Pthlh mRNA abundance in vehicle or omeprazole-treated 
mice with a single daily i.p. injection of omeprazole (400 μmol/kg) for 4 days.  Values 
were normalized to Gapdh. B) H+ concentration in stomach contents of vehicle and 
omeprazole-treated mice. Data are means ± SEM, ** P < 0.05. (N=5). 
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CHAPTER 3 
THE FUNCTION OF PARATHYROID HORMONE-LIKE HORMONE 
 IN THE DEVELOPING MOUSE STOMACH 
3.1 SUMMARY 
My studies described in chapter 2, demonstrated that Pthlh is a novel parietal 
cell growth factor that is regulated by gastrin. Pthlh is known to be expressed 
broadly in a number of tissues and has been described to orchestrate key cellular 
events, such as cell proliferation and differentiation. Although Pthlh is known to also 
be expressed in gastric tumors, its normal function in the stomach is unknown. In 
this chapter, I took advantage of the genetically engineered PthlhLacZ/+ knock in 
mouse strain to study the function of Pthlh in the developing stomach by analyzing 
Pthlh LacZ/LacZ nulls. Since these mice are perinatal lethal, this analysis focused on 
immature embryonic day 18.5 (E18.5) and postnatal day 0 (P0) stomach. This 
analysis showed that the stomach of Pthlh null mice was normal, with morphology 
and cell marker expression similar to wild-type. Our findings suggest that Pthlh 
mutant mouse model has no obvious gastric changes, which may be due to maternal 
compensation with Pthlh found in the amniotic fluid. 
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3.2 INTRODUCTION 
 In the stomach, regulation of gastric homeostasis is not fully understood. One 
important consideration is the growth factors secreted by parietal cell, which may 
preserve a healthy balance between proliferation and differentiation1. Recent 
microarray studies identified parathyroid hormone-like hormone (Pthlh) as a novel 
growth factor expressed by gastric epithelial cells2-4.  Pthlh was first identified as the 
causative factor for hypercalcemia of malignancy, in which tumors that secrete this 
hormone increase serum calcium levels by promoting bone and renal tubular 
calcium resorption through the activation of the parathyroid hormone receptor 
(Pth1r)5. In addition to association with malignancy, the wide expression of Pthlh in 
many systems during development and in mature tissues suggests a central role for 
Pthlh in physiological homeostasis6, 7. Although Pthlh was known to be expressed in 
the stomach, little is known about the regulation or the function of Pthlh in this 
organ. For example, there were discrepancies about the cellular localization of Pthlh 
in the stomach with some studies suggesting that Pthlh is expressed in epithelial 
cells while others found mesenchymal expression of Pthh8-11. Moreover, although 
Pthlh has been known to have a wide range of functions in many body systems,  
including calcium homeostasis, cell proliferation and cell differentiation7, the 
function of Pthlh in the stomach was poorly understood and limited to a possible 
involvement in gastric smooth muscle relaxation10.  
 Therefore, this chapter focused on identifying the normal gastric function of 
Pthlh by taking the advantage of PthlhLacZ/+ and PthlhLacZ/LacZ mice12. 
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3.3 MATERIALS AND METHODS 
Mice 
 All experiments were performed according to protocols approved by the 
University of Michigan Committee on Use and Care of Animals. Mice were 
maintained in specific-pathogen-free barrier facilities under a 12-hour light/dark 
cycle. PthlhLacZ/+ 12 mice (gift from A. Broadus), were maintained on mixed a CD-1 and 
C57BL/6 strain background. Stomachs at postnatal day 0 (P0) or at embryonic day 
E18.5 were obtained from intercrossing PthlhLacZ/+ mice. The morning of the day of 
presence of a vaginal plug was taken to be embryonic day 0.5 (E0.5). This mating 
gives rise to PthlhLacZ/LacZ nulls, which were used for Pthlh functional studies, 
PthlhLacZ/+, which were used for Pthlh expression analysis, and wild type mice, which 
were used for controls. 
Tissue Collection and Analysis of Gene Expression 
 For E18.5 embryonic stomachs, RNA was isolated from whole stomachs 
using the RNeasy Mini Kit according to the manufacturer’s instructions. cDNA 
syntheses and qRT-PCR analyses were performed as described previously in 
chapter 2. Table 3-1 lists primers used to carry out the qRT-PCR analyses.
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Table 3 - 1: Oligonucleotide primers (5’ to3’) for quantitative reverse transcription polymerase chain 
reaction 
  
Gene Forward Reverse Size (bp) 
Gapdh TCA AGA AGG TGG TGA AGC AGG TAT TAT GGG GGT CTG GGA TGG  350 
Pthlh GAC GTA CAA AGA ACA GCC ACT CA TTT TTC TCC TGT TCT CTG CGT TT 81 
H+,K+-ATPase α TGT ACA CAT GAG AGT CCC CTT G GAG TCT TCT CGT TTT CCA CAC C 157 
H+,K+-ATPase β AAC AGA ATT GTC AAG TTC CTC AGA CTG AAG GTG CCA TTG 140 
Gastrin GGACCAGGGACCAATGAGG CCAAAGTCCATCCATCCGTAGG 173 
Pth1r AAG TGG TGG CAG TAC CTT GTC GTCC CCC GTT CCC GAG TCT CAT TGG 171 
IF CTT GGC CCT GAC CTG TAT GT TAG GTT GCT CAG GTG TCA CG 191 
Sm22α CTC TAA TGG CTT TGG GCA GTT TGG GCT CCT GGG CTT TCT TCA TAA ACC 90 
Vimentin ACT GCT GCC CTG CGT GAT GTG GGT ACT CGT TTG ACT CCT GCT TGG 163 
Desmin AGA CCT TCT CTG CTC TCA ACT TCC CTC GCT GAC AAC CTC TCC ATC C 122 
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X-Gal Staining    
For regular X-gal staining, wild type or PthlhLacZ/+ stomach and intestine 
cryosections (8µm) were dried at room temperature for 5 minutes, and then fixed in 
4% PFA for 5 minutes before performing x-gal staining as described in chapter 2 
with neutral red as a counterstain.  
For whole mount X-gal staining, gastrointestinal tracts were dissected and 
fixed in 4% PFA for 1 hour before performing whole-mount X-gal staining, as 
described in chapter 2.   
Immunohistochemistry Analyses 
For E18.5 stomach analysis, pregnant female mice were injected 1.5 h before 
embryo collection with 5-bromo-2-deoxyuridine (BrdU 50 mg/kg ip; Sigma), freshly 
prepared in normal saline (0.9% NaCl, pH 7.4). Stomachs were dissected and fixed 
overnight in 4% PFA as described previously13.  Proliferating cells were identified 
by immunostaining 4µm paraffin sections for BrdU (1:50 dilution of mouse 
monoclonal antibody; Dako).  
For P0 null stomach analysis, stomachs were collected and fixed for 1 hour in 
4% PFA then incubated overnight in 30% sucrose in 1XPBS. Gastric cell types were 
identified by immunostaining cryosections (8 µm) with a mouse monoclonal 
antibody to the H+, K+-ATPase α subunit (1:500; Medical and Biological 
Laboratories) for parietal cells and a polyclonal antibody to gastric intrinsic factor 
(1:1,000 rabbit anti-human; gift from D. Alpers, Washington University St. Louis, St. 
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Louis, Missouri, USA) for zymogenic cells. Staining and secondary antibody use were 
done as previously described13. Sections were stained with biotin-conjugated 
secondary antibodies (1:200; Vector Labs) for 30 min at room temperature and 
visualized by using the Vectastain Elite ABC kit (Vector Laboratories), developed 
with DAB and counterstained with hematoxylin. 
Statistics 
 Quantitative data are presented as mean ± SEM and analyzed by student’s t-
test (Graph Pad Prism) with P < 0.05 considered significant.  
3.4 RESULTS 
The goal of this study was to determine the normal function of Pthlh in the 
mouse stomach by analyzing homozygous PthlhLacZ/LacZ mice.  Pthlh mutants are 
perinataly lethal14, 15, thus we initially examined Pthlh mutants at P0. The gross 
morphology of the stomach of P0 Pthlh mutants showed a dramatic reduction in size 
compared to control stomachs. (Figure 3-1, B). This difference was likely due to the 
inability of the Pthlh-null mice to feed, thus not stretching the stomach as in 
controls. Consequently, Pthlh-deficient gastric mucosa appeared to be expanded 
compared to normal stomach (Figure 3-1, C and D). To determine whether 
differentiated epithelial cells were formed, Pthlh mutant and control stomach 
sections were stained with H+,K+-ATPase and IF to assess parietal cells and 
zymogenic cells, respectively (Figure3-1, E-H). This analysis showed that these 
differentiated cell types were formed in null stomach. 
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Figure 3 – 1: Pthlh mutant stomach phenotype at P0. A, the phenotypic 
appearance of Pthlh nulls compared to the controls. The Pthlh mutants have 
domed skulls, short snouts and mandible-protruding tongues. These skeletal 
abnormalities prevent the mutants from feeding. B, Pthlh-deficient P0 stomach is 
reduced in size compared to control. Hematoxilin and eosin, H+,K+-ATPase or 
intrinsic factor stained frozen sections for control (C, E and G) or Pthlh-deficient 
(D, F and G) P0 stomachs. Pthlh mutants at P0 appeared to have expanded 
mucosa compared to normal stomach. Scale bar = 100 μm. 
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Because the stomachs of control mice were filled with milk compared to Pthlh-
deficient P0 (Figure 3-1, B), we examined Pthlh mutants at E18.5 to avoid any 
possible artifact resulting from gastric wall stretching. The first striking finding was 
that the dramatic reduction in stomach size seen in the Pthlh P0 nulls was 
eliminated and both groups had the same stomach size at E18.5 (Figure 3-2, A and 
B), thus suggesting that the apparent difference in mucosal morphology at P0 was 
due to stretching. By analyzing the stomach morphology with hematoxylin and eosin 
stained sections, no changes were observed in the E18.5 Pthlh-deficient prenatal 
mucosa compared to controls (Figure 3-2, A-D). To determine if epithelial cell 
proliferation was changed, gastric sections were stained with BrdU (Figure 3-2, E-
F), with no change found in Pthlh mutant stomach. This was in agreement with the 
unchanged expression of the proto-oncogenes c-Myc and N-Myc known to be 
involved in promoting proliferation (Figure 3-3, D-E)4, 16. Although Pthlh mRNA was 
absent in the Pthlh-deficient stomach, expression of Pth1r and the Pthlh target 
transcription factor SRY-box containing gene 4 (Sox4) were not changed17 (Figure 3-
3, A-C).  
To test if there are changes in gastric differentiation of Pthlh mutants, 
epithelial and mesenchymal marker expression was measured. Epithelial marker 
expression specific to parietal cells and zymogenic cells was first analyzed. There 
were no changes in H+,K+-ATPase-α and IF expression by qRT-PCR and 
immunohistochemical analysis between Pthlh mutant and control stomachs (Figure 
3-4, A-F). There were, however, modest mesenchymal changes in mesenchymal cell 
marker expression in mesenchymal cell marker expression with significant  
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Figure 3 – 2: Pthlh mutant stomach at E18.5 does not differ from normal 
stomach. (A-B) Gross morphology, (C-D) Hematoxylin and eosin stained sections, 
and (E-F) BrdU stained sections of E18.5 control or Pthlh mutant stomachs. Scale 
bar = 100 μm. 
Z 
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Figure 3 – 3: Pthlh mutant stomach at E18.5 does not differ from normal 
stomach. Total stomach RNA of controls or Pthlh mutants were analyzed by qRT-
PCR for Pthlh, Pth1r, Sox4, c-Myc and N-Myc genes. ** P <0.01 and all data (mean 
± SEM) are shown in reference to Gapdh expression measured in the same 
samples (N = 5-6). 
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Figure 3 – 4: Differentiated epithelial gastric cell marker expression is not 
changed in E18.5 Pthlh mutant stomach. A, qRT-PCR analyses for H+,K+-
ATPase-α or IF in control and Pthlh mutant stomach. ** P <0.01 and all data 
(mean ± SEM) are shown in reference to Gapdh expression measured in the same 
samples (N = 5-6).Immunostaining for sections of Pthlh mutant or control 
stomach sections using H+,K+-ATPase (B-C) and intrinsic factor (D-E) antibodies. 
Scale bare = 100 μm. 
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reduction in the smooth muscle specific marker SM22α. This result suggested that 
smooth muscle cells might be targets for Pthlh (Figure 3-5 A-C). 
Since the analysis of Pthlh mutant stomach at E18.5 did not show major 
changes in the gastric mucosa, we wanted to know if Pthlh is expressed in stomach 
during fetal gastric development by analysis of LacZ expression. Pthlh was found to 
be restricted to the forestomach epithelium at E18.5. Thus Pthlh expression was not 
observed in the developing gastric glandular epithelium (Figure 3-6, B-C). In 
contrast, Pthlh was highly expressed in the developing intestinal villus-epithelium.  
(Figure 3-6, D-E), which implies the importance of Pthlh in intestinal development.  
3.5 DISSCUSION 
Pthlh is a growth factor that is expressed widely in different tissues in both 
developmental and postnatal tissues. Pthlh is known to have numerous functions in 
normal tissues as well as to be highly expressed in many cancers6, 18, 19. This chapter 
aimed to find the function of Pthlh in the stomach by analysis of Pthlh null mice12. 
Although the Pthlh null stomach at P0 showed apparent mucosal expansion (Figure 
3-1, C-H), the E18.5 null stomach showed no major differences between mutants 
and control stomach. The Pthlh mutants have skeletal abnormalities that affect the 
newborn mouse milk suckling. My data suggests that the mucosa of the control P0 
stomach is thinner and stretched in organization compared to the mutants due to 
the lack of feeding. Furthermore, Pthlh is known to be high in both the mother’s 
amniotic fluid20 as well as mother’s milk21. Thus loss of Pthlh in the developing 
stomach may be compensated for by maternal sources. Pthlh mutants did not show 
any changes in stomach size, gastric mucosa organization or differentiated epithelial
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Figure 3-5 Differentiated mesenchymal gastric cell marker expression had minor changes in Pthlh mutant stomach. 
qRT-PCR analyses for SM22α, vimentin and desmin in control and Pthlh mutant stomach. ** P <0.01 and all data (mean ± 
SEM) are shown in reference to Gapdh expression measured in the same samples (N = 3-6). 
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Figure 3 – 6: Pthlh expression in the gastrointestinal tract at E18.5. Whole mount X-gal staining for E18.5 (A) 
gastrointestinal tract, (B) forestomach, (C) glandular stomach, (D) proximal intestine, (E) distal intestine, and (F) colon of a 
PthlhLacZ/+embryo. 
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cellular compositions of the gastric gland. The only change was very minor and was 
seen in the reduction of the mesenchymal smooth muscle cell marker SM22 
(Figure 3-5, A). This result might suggest that Pth1r is expressed in the 
mesenchyme. Since maternal expression of Pthlh in amniotic fluid and milk 
complicates the analysis of developing stomach, the best way to study Pthlh 
function, is by analyzing the Pth1r mutant. The receptor mutant generally shows 
more severe phenotypes compared to the Pthlh mutant22. The last reason for not 
seeing a phenotype in the Pthlh null mouse stomach is that my data shows that 
there is no expression of Pthlh in the glandular mucosa (Figure 3-6, A-C). Pthlh is 
only expressed in epithelial cells of the forestomach in the developing stomach. As 
we saw previously in chapter 2, this expression changes in the adult stomach, and 
Pthlh was mainly expressed in the mature stomach corpus with little expression in 
forestomach. Pthlh was highly expressed in the developing intestinal mucosa with 
specific expression on the villus-epithelial cells. However, the gastric pattern of 
endogenous mRNA Pthlh expression increases between P0 and mature stomach 
(Figure 3 – 7). This pattern agrees with a previous study that showed gastrin and 
H+,K+-ATPase expression did not reach mature levels until several weeks after birth 
(Keeley and Samuelson, 2010). Overall, my data suggest that Pthlh-null mouse is an 
imperfect model to study Pthlh function in the developing stomach. Possible 
alternative models are summarized in Chapter 5. 
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Figure 3 – 7: Pthlh mRNA expression increases gradually during stomach 
maturation. qRT-PCR measurement of Pthlh mRNA abundance in  whole 
stomachs ( P0 and 1 week) or corpus (3, 5 and 8 weeks) of wild type mice. Data 
(means ± SEM) are shown in reference to Gapdh expression measured in the 
same samples (N= 3).  
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CHAPTER 4 
HEDGEHOG SIGNALING DOES NOT MEDIATE GASTRIN INDUCTION  
OF PTHLH GENE EXPRESSION 
4.1 SUMMARY 
Although Pthlh gene expression is known to be regulated by the Hedgehog 
(Hh) signaling pathway in different systems, such as bone morphogenesis and 
mammary cell differentiation, whether similar regulation takes place in the stomach 
is unknown.  My results from chapter 2 showed that gastrin regulates Pthlh 
expression in the parietal cells. Gastrin has been previously shown to regulate Shh 
and Ihh ligand expression in the stomach. Thus this chapter aimed to test the role of 
the Hh pathway in mediating the induction of Pthlh gene expression by gastrin.  
Levels of both Hh ligand and target gene expression by qRT-PCR were not changed 
in both gastrin-deficient and gastrin-injected mouse stomachs. Moreover, I found 
that Pthlh gene expression is not changed in different Hh mutant mouse models, 
such as the developing stomachs of Gli2 and Gli3 mutants, as well as the parietal 
cell-specific Shh-deficient mature stomach. These data suggest that the Hh pathway 
does not mediate the induction of Pthlh expression by gastrin and is not required for 
Pthlh gene expression. 
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4.2 INTRODUCTION 
Parietal cells express several growth factors with central roles in stomach 
homeostasis. Chapter 2 demonstrated how the growth factor Pthlh is specifically 
expressed by parietal cells in mature stomach. It also briefly touched upon the role 
of gastrin in stimulating Pthlh mRNA transcripts expression via the Cckbr. The 
precise mechanism, however, is undetermined. 
The Hedgehog (Hh) signaling pathway is a key signaling pathway in 
gastrointestinal development, differentiation and homeostasis1-4.  The Hh ligands 
are normally expressed by gastric epithelial cells, while the Hh targets are expressed 
by mesenchymal cells5. Analysis of several Hh mutants showed abnormal gastric 
mucosal architecture and reduced stomach size2, 3.  Moreover, studies which 
examined human gastric tumors suggested an association between aberrant Shh 
protein processing and gastric tumor formation6. 
In the stomach, different studies have implied the regulation of gastric Hh 
expression by gastrin. In parietal cell-specific, Shh-deficient mice, the increased Ihh 
expression in the surface pit cells was due to high gastrin levels in these mice7. 
Moreover, one report has demonstrated that gastrin treated mice have high Shh 
mRNA and protein expression6. 
In bone and mammary tissues, different studies strongly suggested the 
induction of Pthlh mRNA expression by Hh8-11.  Therefore, the goals of this chapter 
were: first, to find if Hh regulates Pthlh gene in the stomach. Second, to investigate 
whether Hh signaling mediates gastrin-induced Pthlh gene expression in parietal 
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cells. To achieve these goals, gastrin as well as Hh mutant mouse models were 
tested. 
4.3 MATERIALS AND METHODS 
Mice 
All experiments were performed according to protocols approved by the 
University of Michigan Committee on Use and Care of Animals. Mice were 
maintained in specific-pathogen-free barrier facilities under a 12-hour light cycle. 
Mice were generated as described previously: gastrin mutant12, ShhLacZ/+ reporter 
mouse 13,  and PthlhLacZ/+ reporter mouse14 (gift from A. Broadus). The Gli1LacZ/+ 
reporter mouse 15 , Gli2lacZ/+ knock in mutant15 and the extra toes-J spontaneous 
mutation Gli3xtj/+ mutant16 were obtained from the Jackson Laboratories (stock 
numbers  002448, 007922 and 000026, respectively). Adult heterozygous ShhLacZ/+ 
and Gli1LacZ/+ reporter mice were used to study normal gastric expression while the 
adult gastrin-deficient mouse, and E18.5 Gli2lacZ/LacZ or Gli3xtj/xtj  homozygous null 
embryos were used to measure Pthlh mRNA abundance in the stomach. 
Immunohistochemistry Analysis  
Frozen stomach sections (8μm) were co-immunostained with rabbit anti β-
galactosidase antibody (1:1000, gift from J. D. Engel) followed by the mouse anti 
H+,K+-ATPase-α (1:500, Medical and Biological Laboratories) or simultaneously with 
rat anti keratin-8 (1:50, Developmental studies), followed by incubation with 
appropriate secondary antibodies conjugated to Cy2 or Cy3, as described in the 
Materials and Methods section of chapter 2.  
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Tissue collection and gene expression analysis  
 For adult mice, stomachs were dissected and opened along the greater 
curvature. The corpus was then isolated and stored at -80˚C until the time of RNA 
isolation. Trizol (Invitrogen) was used to isolate RNA as recomended by the 
manufacturer. RNA was DNase-treated and purified using the RNeasy Mini Kit 
(Qiagen). For E18.5 embryonic stomachs, RNA was isolated using the RNeasy Mini 
Kit, according to the manufacturer’s instructions. Gene expression was measured by 
quantitative reverse transcription-PCR (qRT-PCR) analysis, using cDNA (2 µl) that 
was reverse-transcriped from 1µg of RNA template (iScript cDNA Synthesis kit, Bio-
Rad). qRT-PCR was performed as described previously17 with SYBR green dye and 
primers listed in (Table 4-1). Expression levels were determined with triplicate 
assays per sample and normalized to the expression of Gapdh, which remained 
constant for both control and experimental groups. 
Corpus RNA samples from Shh loxP18 crossed to H+,K+-Cre19 were a gift from Y 
Zavros ( University of Cincinnati). 
Statistics 
Data are presented as mean ± SEM and analyzed by Student’s t-test or one way 
ANOVA (Graph Pad Prism) followed by Tukey post-test. P < 0.05 was considered 
significant.
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Table 4 - 1: Oligonucleotide primers(5’ to 3’) for quantitative reverse transcription polymerase chain reaction 
Gene Forward Reverse Size (bp) 
Gapdh TCA AGA AGG TGG TGA AGC AGG TAT TAT GGG GGT CTG GGA TGG  350 
Pthlh GAC GTA CAA AGA ACA GCC ACT CA TTT TTC TCC TGT TCT CTG CGT TT 81 
H+,K+-ATPase α TGT ACA CAT GAG AGT CCC CTT G GAG TCT TCT CGT TTT CCA CAC C 157 
Shh ATG TTT TCT GGT GAT CCT TGC T ATC GTT CGG AGT TTC TTG TGA T 200 
Ihh ACC ATT GAG ACT TGA CCA GGT T TGG AGT AAG CAG TCC AAA GAC A 172 
Ptc1 CTG CTG TGG TGG TGG TAT TC GGC TTG TGA AAC AGC AGA AA 120 
Gli1 TTG GGA TGA AGA AGC AGT TG GGA GAC AGC ATG GCT CAC TA 145 
Gli2 ACC CAA CTC AGC AGC AGT AGC GCT CCG CTT ATG AAT GGT GAT GG 114 
Gli3 CCC TCC GCT CCT GTG TCT CTT C CAG ACT CGC TTG TGG GCT TGC 214 
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4.4 RESULTS 
 We first wanted to confirm the normal expression of Hh members in the 
gastric mucosa. Analysis of ShhLacZ/+ and Gli1LacZ/+ mice confirmed the epithelial 
expression of Shh and the mesenchymal expression of Gli1 in adult stomach, as 
described previously (Figure 4-1)5. To test the hypothesis that Pthlh induction by 
gastrin is mediated by Hh, we first wanted to investigate if gastrin modulates the Hh 
signaling pathway in the stomach by analysis of gastrin-deficient mice. Although 
both Pthlh and the parietal cell marker H+,K+-ATPase- mRNA abundance were 
significantly reduced in the gastrin mutant, the various Hh signaling components 
were unchanged, including the ligands Shh and Ihh, and targets: patched 1(Ptc1), 
Glioma-associated oncogenes(Gli1, Gli 2 and Gli 3) (Figure 4-2, A-H). These results 
suggest that this pathway is not regulated by gastrin. 
 We next tested this hypothesis by acutely injecting wild-type mice with 
gastrin. Hh expression was measured at 1, 2 or 4 hours after gastrin treatment to 
examine if the rapid and transient induction in Pthlh gene expression is preceded by 
an activation of Hh signaling. Analysis of the Hh pathway components by qRT-PCR 
showed that the gene expression of Hh ligands and targets did not change (Figure 4-
3, A-F). This result suggested that induction in Pthlh mRNA by gastrin is not 
associated with a stimulation of Hh signaling. 
 To make sure that Hh is not inhibited by Pthlh, as has been described in bone 
growth and morphogenesis20, we measured the expression of Hh pathway 
components in the E18.5 Pthlh mutant stomach, again observing that Hh signaling  
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Figure 4 – 1: Hh expression in adult stomach. Co-immunostaining adult 
ShhLacZ/+ (A) and Gli1LacZ/+ (B) stomach sections using β-gal and H+,K+-ATPase α 
or keratin-8 antibodies showed that Shh is epithelial and Gli1 is mesenchymal. 
Note the nuclear localization of LacZ in Shh and Gli1 strains.  
ShhLacZ/+ Gli1LacZ/+ 
β – gal 
HK-α 
β – gal 
Keratin8 
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Figure 4 – 2: Hh signaling pathway is not altered in gastrin-deficient mice. 
qRT-PCR measurement of Pthlh, H+,K+-ATPase α, Shh, Ihh, Ptc1 and Gli1-3 gene 
expression of the gastrin-deficient corpus compared to littermates. Data (mean ± 
SEM) are shown in reference to Gapdh expression measured in the same samples 
(N = 4-5; * P < 0.05). 
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Figure 4 – 3: Hh signaling pathway is not altered in gastrin-treated mouse. 
qRT-PCR measurement of corpus Shh, Ihh, Ptc1 and Gli1-3 gene expression of 
gastrin-injected mice (250µg/Kg) at 1, 2 or 4 hours compared to vehicle-treated 
mice. Data (mean ± SEM) are shown in reference to Gapdh expression measured 
in the same samples (N = 5; * P< 0.05). 
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Figure 4 – 4:  Hh signaling pathway is not altered in Pthlh mutant stomach. qRT-PCR measurement of Shh, 
Ihh, Ptc1 and Gli1-3 gene expression of the  E18.5 Pthlh-deficient stomach compared to littermates. Data 
(mean ± SEM) are shown in reference to Gapdh expression measured in the same samples (N = 5-6; * P< 
0.05). 
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activity was not changed (Figure 4-4, A-F). Lastly, three different Hh mutant mouse 
models were tested to investigate if disruption of the Hh pathway affects Pthlh in 
the stomach. There was no change in Pthlh mRNA expression in the adult parietal 
cell-specific Shh-deficient corpus H+,K+-Cre/Shh -/- (Figure 4-5). Moreover, 
measurements of Pthlh gene expression in E18.5 stomachs from the Gli2 and Gli3 
mutants did not differ from controls (Figure 4-5, B and C).  
Together, these data demonstrate that Hh signaling does not regulate Pthlh 
gene expression in the stomach.   
4.5 DISCUSSION 
 This study examined five different mouse models to answer three questions: 
(1) does gastrin regulate the Hh signaling pathway? (2) is Hh signaling required for 
Pthlh gene expression in the stomach? and (3) does Pthlh regulate Hh signaling in 
the stomach? To answer the first question, both gastrin mutants and gastrin-treated 
mice were examined. This study demonstrated that the Hh signaling pathway 
activity was not gastrin-regulated. These results were surprising since Zavros et al 
previously found that gastrin induced Shh mRNA and protein expression in both 
wild-type and gastrin mutant mice6. However, there are some differences in the 
methods used in that study compared to our study. Our study acutely examined 
responses within hours of G-17 gastrin-treatment, while Zavros et al. found Shh 
expression was induced after infusion with a mixture of G-17 and G-17gly for 14 
days. The chronic treatment and mixture of gastrin forms might be required for Hh 
induction. 
Figure 4 - 1 Pthlh mRNA expression in Different Hh mutant mouse models. qRT-
PCR measurement of Pthlh gene expression of the adult HKCre/ShhKO stomach or 
the E18.5 Gli2 or Gli3 mutant stomachs compared to control littermates. Data 
(mean ± SE) are shown in reference to Gapdh expression measured in the same 
samples (n = 4-6). 
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Figure 4 - 5: Pthlh mRNA expression in adult Hh mutant mouse model. qRT-
PCR measurement of Pthlh gene expression of the adult H+,K+-Cre/Shh-/- stomach 
compared to control littermates. Data (means ± SEM) are shown in reference to 
Gapdh expression measured in the same samples (N = 4). 
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Figure 4 - 6: Pthlh mRNA expression in Hh mutant mouse model. qRT-PCR 
measurement of Pthlh gene expression of E18.5 Gli2 or Gli3 mutant whole 
stomachs compared to control littermates. Data (means ± SEM) are shown in 
reference to Gapdh expression measured in the same samples (N = 4). 
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To answer the second question, H+,K+-Cre /Shh -/- adult stomach corpus, as 
well as E18.5 stomachs of Gli2LacZ/LacZ and Gli3xtj/xtj mutants, were analyzed. We did 
not see a significant change in the Pthlh mRNA abundance in the H+,K+-Cre /Shh-/- 
mice. This could be due to the complexity of the phenotypes associated with this 
mouse model7, or simply that deleting Shh in parietal cells does not affect Pthlh 
expression. Although these mice have lower levels of total corpus Shh, Ihh and Gli1 
were increased, suggesting activated Hh signaling7. Moreover, this mouse model is 
hypergastrinemic due to aberrant tubulovesicles in parietal cells7. All of these 
factors together make it difficult to predict how Pthlh gene regulation might be 
affected by the Hh pathway.  
The unchanged Pthlh mRNA expression in the Gli2 and Gli3 mutants suggests 
that these transcription factors are not required for Pthlh gene expression 
regulation, probably due to the absence of Pthlh expression in embryonic glandular 
stomach, as I demonstrated in the previous chapter. Although other studies focused 
on bone mophogenesis10, 11, 20, 21 and mammary gland metastasis8, 9 showed 
induction in Pthlh by different Hh signaling members such as Shh, Ihh and Gli2, until 
now their regulation was not understood due to the absence of a consensus Gli 
binding site on the Pthlh gene promoter 8. This might suggest the presence of non-
canonical Gli binding sites in the Pthlh promoter or indirect regulation of this gene. 
Another important point is that Hh target genes have been found to be primarily 
expressed in mesenchymal cells5. Since the induction of parietal cell Pthlh 
expression by gastrin is very rapid, it will be harder for Hh to mediate this induction 
if the site of Hh activation is limited to the mesenchyme5.    
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Lastly, our results confirmed that Pthlh is not required for the stimulation of 
Hh signaling pathway in the stomach, as described previously in bone20. Analyses in 
this chapter clearly suggest that Hh pathway is not mediating the induction of Pthlh 
by gastrin in the stomach.
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CHAPTER 5  
CONCLUSIONS AND FUTURE DIRECTIONS 
 
This dissertation aimed to study the novel parietal cell growth factor Pthlh in 
the stomach in several ways, including normal gastric expression, gene regulation 
and gene function. Although this study examined different aspects of this growth 
factor in the stomach, there are still several remaining areas to be examined and 
questions to be answered. It is important that many of these questions are not 
limited to stomach, but they extend to understanding Pthlh function in other organs 
and systems as well. As mentioned in Chapter 1, human Pthlh has a complex gene 
structure, giving rise to numerous transcripts, which are translated and processed 
to produce a number of different mature proteins. So far, only three possible 
bioactive protein products have been identified to result from post translational 
processing, and not all of these Pthlh proteins have a recognized receptor. Currently 
there is nothing known about which of these peptides might be expressed in the 
stomach. 
This chapter will focus on summarizing key conclusions from my research as 
well as exploring possible future experiments that can be done to answer the 
remaining questions about the role of Pthlh in the stomach. 
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I. Pthlh Gastric Expression 
By analyzing the PthlhLacZ/+ 1 reporter mouse, I found that Pthlh was found to 
be expressed normally in both developing and mature stomach but in distinct 
stomach compartments. At day E 18.5, Pthlh expression is limited to the squamous 
epithelial cells in the forestomach. In the mature stomach, however, Pthlh is 
specifically expressed in parietal cells in the corpus. This change in expression 
pattern between different region of the stomach has been observed with other 
genes such as the Shh2 and DCLK13; however the reason for this differential 
expression during gastric development is unknown. Moreover, the Pthlh-positive 
parietal cells are more abundant in the few first glands near the squamo-glandular 
junction. This region has attracted the attention of many studies lately, due to the 
large number of the newly discovered tuft cell lineage in this location3, high 
expression of key gastric homeostatic signaling pathway proteins such as Shh4, and 
because of the formation of tumors in this junction (personal communication, 
Andrzej A. Dlugosz). A microarray study of these few glands during development 
and/or in normal human and mouse gastric cancer models may help to uncover the 
specific properties of this interesting region.    
Knowing that Pthlh produces at least three proteins: (Pth-like, mid-region 
and the carboxyl-end, reviewed in Figure 1 - 4), it will be important to generate and 
test antibodies specific for each Pthlh protein-product by immunohistochemical 
analysis or other approaches to find if they exhibit different expression patterns in 
the stomach. Different radio-immunoassays (RIA)5 have been developed against 
118 
 
Pthlh (1-34)6, (37-67)7 and (109-138)8 regions using rabbit antiserum. Protein 
extracts from isolated parietal cells9 can be analyzed for specific Pthlh-peptides to 
measure the expression of each Pthlh peptide in parietal cells.  
II. Pthlh Gastric Function 
This project had limitations in determining the normal gastric function of 
Pthlh due to the perinatal lethality of Pthlh-deficient mouse. In addition, the 
maternal Pthlh compensation for absent Pthlh in Pthlh-deficient embryos is likely to 
compensate for Pthlh loss in the embryo. In spite of these limitations, I observed 
minor differences in the expression of some mesenchymal markers specific to 
myofibroblast and smooth muscle cells in the Pthlh-deficient developing stomach. 
Immunohistochemical analysis using actin smooth muscle alpha (SM22α) or desmin 
antibodes followed by morphometric analysis for both normal and Pthlh null 
stomachs might give a better sense about whether Pthlh affects mesenchymal cell 
number. However, an in vitro organ culture system may be required to understand 
the specific contribution of maternal versus fetal Pthlh for stomach development. 
Another way to study the function of Pthlh in mature stomach is to target 
Pthlh expression in parietal cells by crossing the H+,K+-Cre10 mouse to the floxed 
Pthlh transgenic mouse11. The resulting parietal cell-specific Pthlh-deficient mouse 
will avoid perinatal lethality as well as the difficulties that arise from existence of 
maternal Pthlh sources found in the developing Pthlh-deficient embryos. This 
approach would escape the health complications (lack of tooth eruption, skeletal 
defects and short lifetime) found in the commonly used “rescued” Pthlh-deficient 
119 
 
mouse, in which the whole body lacks Pthlh, but the Pthlh receptor (Pth1r) is 
constitutively activated in the bone growth plate12. The stomach parietal cell specific 
H+,K+-Cre/Pthlh -/- mouse will allow critical analysis of Pthlh function in the mature 
stomach. Immunohistochemical analysis with specific cell lineage makers (Table 1-
1) can be used to evaluate the role of parietal cell Pthlh on mature gastric gland 
differentiation. Proliferation measurements by BrdU staining followed by 
morphometric analysis, can be used to test if Pthlh stimulates proliferation, as has 
been suggested in gastric tumors13, 14.  
Since PthlhLacZ/LacZ null mice combine phenotypes resulting from the absence 
of all bioactive Pthlh proteins, it will be interesting to analyze other mouse models 
that specifically target each of the potential bioactive Pthlh proteins. The Pth1r-
deficient embryos15, which deletes the Pth-like protein receptor (Pth1r), can be 
studied to understand the function of the Pth-like Pthlh in the stomach. However, 
although these mice are specific to a single Pthlh protein, Pth1r null die by mid-
gestation15, and this would not be usful for study of the stomach because gastric 
development is not complete until after birth16.  The new mouse model Pthrp Δ/Δ17, 
however, can live longer (5-20 days). The Pthrp Δ/Δ  mouse is designed to 
permanently eliminate the expression of mid-region and C-terminus Pthlh proteins 
by replacing the DNA sequence responsible for the production of Pthlh-(67–137) aa 
with a floxed Neo cassette. The Pthrp Δ/Δ mice demonstrate severe skeletal defects as 
well as hematopoiesis17; the stomach has not been analyzed. 
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Although the receptors for some of the Pthlh proteins are not yet identified, 
there are several commercially available Pthlh reagents that are currently available 
to understand the specific role of each Pthlh bioactive protein. My research 
suggested the expression of Pth1r in developing and mature stomach as well as in 
several human gastric cancer cell lines, as demonstrated in Chapter 2. To find the 
role of Pthlh for proliferation and differentiation, wild type mice, mouse gastric 
epithelial cell primary cultures, and human gastric cell lines can be treated with any 
of the Pthlh synthetic proteins: Pthlh (1-37) agonist18, Pthlh (4-37) antagonist19 or 
Pthlh (107-139) agonist20, 21. These experiments can be followed up to analyze the 
Pthlh effect on: (i) cell proliferation, using Ki67, BrdU immunohistochemistry and 
proliferation assays, (ii) differentiation, using qRT-PCR, western blots and 
immunohistochemistry specific for each gastric cell lineage, and (iii) apoptosis, 
using cleaved-caspase-3 and Tunel staining. Using these Pthlh synthetic proteins is 
advantageous because it will help define the function of Pthlh in the stomach, and 
because it will avoid the Pthlh protein specificity problem found in different Pthlh-
deficient mouse models. 
III. Pthlh Gene Regulation 
One of the main aspects of this study was to understand how Pthlh 
expression is regulated in the stomach. My study showed that Pthlh is transiently 
and rapidly induced by the gastric hormone gastrin in both in vitro and in vivo 
systems, as described in Chapter 2. It also showed that this induction is mediated by 
the gastrin receptor Cckbr, through activation of key signaling pathways, including 
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MAPK ErK1/2, MAPK p38, PKC-α, PI3K and the EGFR pathways. My analysis was 
limited to analysis of Pthlh mRNA abundance after gastrin and/or inhibitor 
treatments. These pathways can be further studied by measuring key 
phosphorylated proteins in each of the signal transduction pathways.  The PKC 
pathway deserves special attention due to its fast response and stimulation of Ca2+, 
and because there is evidence for Ca2+ mediated induction of Pthlh22, 23. There are 
several isoforms of PKC which can be activated by either Ca2+ or other regulators, 
therefore characterizing which PKC isoforms are involved in Pthlh induction by 
gastrin will help to understand the mechanism. Several commercially available 
inhibitors for PKC-α, PKC-βI, PKC-βII, PKC-δ, and PKC-ε in addition to adenoviruses 
that overexpress different PKCs isoforms have been described24 and can be tested to 
understand the regulation of PKC signaling pathways in Pthlh gene induction by 
gastrin. The use of specific PKC adenoviruses is more valuable than pharmacological 
inhibitor due to their high isoform specifity.   
My results suggested that gastrin activates several Pthlh mRNA species, 
which are transcribed under the control of the P1, P2 and P3 promoters. Further 
research is needed to identify response elements controlling Pthlh gene expression 
that are associated with P1, because it was robustly expressed upon gastrin 
administration. Several studies suggested the control of Pthlh by hypoxia-
responsive elements (HRE)25, negative vitamin D response element (nVDRE)26 as 
well as Ets/Sp1 transcription factors binding sites27, 28. These response elements can 
be tested by making serial deletions or point mutations for each Pthlh promoter 
tagged to a luciferase construct, followed by measurements for the luciferase 
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expression in the presence of vehicle versus gastrin. Chromatin 
immunoprecipitation (ChIP) assay can be then applied to identify if specific 
transcription factors bind to the Pthlh gene to show that these transcription factors 
directly target the gene.  
At the post-transcriptional level, I found that gastrin can stabilize Pthlh 
mRNAs and increase their half-life, as described in Chapter 2. The specific 
mechanism behind this phenomenon is currently unknown. The Pthlh mRNAs 
3’UTR contain AU-response elements (AREs), which are usually targets for ARE 
binding proteins29 to affect mRNA stability. Gastrin has been shown to stabilize both 
IL-8 and Cox-230genes via the ARE-binding proteins HuR and TTP31. The HuR 
protein was also found to bind and stabilize Pthlh mRNAs in human renal cell 
carcinomas32. It will be important to determine whether HuR is mediating the 
stabilization of Pthlh by gastrin. This can be tested in AGS-E cells by knocking down 
HuR with specific siRNA and measuring Pthlh expression after gastrin treatments. In 
addition, the cytoplasmic translocation of HuR from the nucleus to the cytoplasm 
can be tested by immunohistochemistry for HuR after AGS-E treatment with gastrin. 
RNA-binding assays can be used to identify and confirm the binding between HuRs 
and ARE elements in 3’UTRs32, 33. The recent study by the Wang laboratory30 
demonstrated HuR protein induction and cytoplasmic localization in gastrin treated 
AGS-E cells. This induction was found to be mediated by p38 MAPK. Accordingly, my 
data proved that Pthlh mRNA induction by gastrin is mediated by p38 as well. 
Moreover, my preliminary analysis suggested that HuR protein is expressed in the 
mouse gastric epithelial cells, including the parietal cell (data not shown).  
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Does Pthlh mediate the proliferation effect of gastrin in the stomach? 
This question is yet to be answered. Although gastrin has been shown to 
induce gastric proliferation both after meal ingestion34 as well as with various 
hypergastrinemic conditions9, the mechanism is not understood. Analysis of adult 
mice with parietal specific deletion of Pthlh (H+,K+-Cre/Pthlh -/-) could be used to 
address the importance of Pthlh for gastrin effects. It will also be important to find if 
the gastric proliferating cells express Pthlh receptor(s), but before that the 
identification of gastric stem cells markers will be essential. The identification 
and/or the manipulation of human gastric cell lines that can be responsive to both 
gastrin and Pthlh will be critical in understanding the mechanism of proliferation 
induced by gastrin via Pthlh. These studies will help especially in the clinical field, 
when we know that gastric cancer is one of the leading causes of death. 
This project used several in vitro and in vivo systems to uncover many 
aspects of parietal cell growth factor (Pthlh) in the stomach. Importantly, my 
dissertation localized Pthlh to the parietal cells, and demonstrated the induction of 
Pthlh gene expression by gastrin in normal gastric tissues and in gastric cancer cell 
lines. There are however many remaining questions on the function of Pthlh and the 
precise regulation by gastrin. Further study is needed to understand the role of 
Pthlh in both healthy and diseased stomach. 
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